Document:

Exhibit 10.1 PFSI DB Amend MRA

		

			Exhibit 10.1

		

		

			 

		

		
			 
		

		
			 
		

		
			DEUTSCHE BANK AG, CAYMAN ISLANDS BRANCH, as buyer (“Buyer”),
		

		
			and
		

		
			PENNYMAC LOAN SERVICES, LLC, as seller (“Seller”),
		

		
			__________
		

		
			AMENDMENT NO. 3
		

		
			dated as of December31, 2018
		

		
			to the
		

		
			MASTER REPURCHASE AGREEMENT
		

		
			dated as of August 21, 2017
		

		
			 
		

		
			 
		

		
			 
		

		
			

		 

 

		

			 

		

		

		
			 
		

		
			AMENDMENT NO. 3 TO MASTER REPURCHASE AGREEMENT
		

		
			This Amendment No. 3 to Master Repurchase Agreement, dated as of December 31, 2018 (this “Amendment”), is entered into by and among Deutsche Bank AG, Cayman Islands Branch (“Buyer”) and PennyMac Loan Services, LLC (“Seller”).  Any capitalized terms not defined herein shall have the meaning assigned to such term in the Master Repurchase Agreement (as defined below).
		

		
			WHEREAS, the parties hereto entered into that certain Master Repurchase Agreement, dated as of August 21, 2017 (as amended, restated, supplemented or otherwise modified from time to time, the “Master Repurchase Agreement”);
		

		
			WHEREAS, the parties hereto desire to modify the Master Repurchase Agreement as described below;
		

		
			NOW, THEREFORE, in consideration of the premises and covenants contained herein and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto, intending to be legally bound hereby, agree as follows:
		

		
			Section 1.        Amendment.
		

		
			(a)        Section 1 of the Master Repurchase Agreement is hereby amended by deleting the definition of “Maximum Amount” in its entirety and replacing them with the following:
		

		
			“Maximum Amount” shall mean $950,000,000.
		

		
			Section 2.        Conditions to Effectiveness of this Amendment.
		

		
			(a)        This Amendment shall become effective upon the execution and delivery of this Amendment by all parties hereto (the “Amendment Effective Date”).
		

		
			(b)        Master Repurchase Agreement Remains in Effect.  Except as expressly amended by this Amendment, the Master Repurchase Agreement remains in full force and effect and nothing in this Amendment shall otherwise affect any other provision of the Master Repurchase Agreement or the rights and obligations of the parties thereto.
		

		
			Section 3.        Expenses.  Seller hereby agrees that in addition to any costs otherwise required to be paid pursuant to the Master Repurchase Agreement, Seller shall be responsible for the payments of the reasonable and documented legal fees and out-of-pocket expenses of legal counsel to Buyer incurred in connection with the consummation of this Amendment and all other documents executed or delivered in connection therewith.
		

		
			Section 4.        Representations; Ratifications Covenants.
		

		
			(a)        In order to induce Buyer to execute and deliver this Amendment, Seller hereby represents and warrants to Buyer that as of the date hereof, Seller is in full compliance with all of the terms and conditions of the Master Repurchase Agreement and no Default or Event of Default has occurred and is continuing under the Master Repurchase Agreement.
		

		
			 
		

		
			 
		

		
			

		 

 

		

			 

		

		

		
			 
		

		
			(b)        The parties hereto ratify all terms of the existing Master Repurchase Agreement other than those amended hereby, and ratify those provisions as amended hereby.
		

		
			Section 5.        Incorporation by Reference.  Sections 13.02 (Notices), 13.11 (Successors and Assigns), 13.13 (Captions), 13.14 (Counterparts), 13.15 (Governing Law; Repurchase Agreement Constitutes Security Agreement), 13.17 (Electronic Signatures), 13.18 (Submission To Jurisdiction; Waivers), 13.19 (Waiver of Jury Trial) and 13.30 (Entire Agreement) of the Master Repurchase Agreement are incorporated herein by reference, mutatis mutandis.
		

		
			[signature pages follow]
		

		
			 
		

		
			 
		

		
			 
		

		
			

		 

		

			2

		

 

		

			 

		

		

		
			 
		

		
			IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be duly executed as of the date first above written.
		

		
			 
		

		
			 
		

		
			DEUTSCHE BANK AG, CAYMAN ISLANDS BRANCH,
as Buyer
		

		
			 
		

		
			 
		

			
					
						By:  

					
					
						/s/ Timothy P. F. Crowley

					
					
						 

				
	
					
						Name:  

					
					
						Timothy P. F. Crowley

					
					
						 

				
	
					
						Title:  

					
					
						Director

					
					
						 

				
	
					
						 

					
					
						 

				
	
					
						 

					
					
						 

				
	
					
						By:  

					
					
						/s/ Genevieve Nestor

					
					
						 

				
	
					
						Name:  

					
					
						Genevieve Nestor

					
					
						 

				
	
					
						Title:  

					
					
						Managing Director

					
					
						 

				

		
			 
		

		
			
		

		
			

		 

		

			Amendment No. 3 to PLS Master Repurchase Agreement

		

 

		

			 

		

		

		
			 
		

		
			PENNYMAC LOAN SERVICES, LLC,
as Seller
		

		
			 
		

		
			 
		

			
					
						By:  

					
					
						/s/ Pamela Marsh

					
					
						 

				
	
					
						Name:  

					
					
						Pamela Marsh

					
					
						 

				
	
					
						Title:  

					
					
						Managing Director, Treasurer

					
					
						 

				

		
			 
		

		 

		

			Amendment No. 3 to PLS Master Repurchase AgreementExhibit 10.1

    

     

    

    
      CONFIDENTIAL

      

      

      FORM OF

      

      

      CONTINGENT VALUE RIGHTS AGREEMENT

      

      

      by and between

      

      

      BRISTOL-MYERS SQUIBB COMPANY

      

      

      and

      

      

      [TRUSTEE]1

      

      

      Dated as of [______], [____]

       

      

      

      

      
        
          	1	
                  Note to Draft:  Trustee to be determined in accordance with the Merger Agreement.

                

        

      

      
        
          

      

      
      

      

      TABLE OF CONTENTS

      

      

      	
              Article 1 DEFINITIONS AND OTHER PROVISIONS OF GENERAL APPLICATION

            	
              1

            
	
              Section 1.1

            	
              Definitions

            	
              1

            
	
              Section 1.2

            	
              Compliance and Opinions

            	
              8

            
	
              Section 1.3

            	
              Form of Documents Delivered to Trustee

            	
              9

            
	
              Section 1.4

            	
              Acts of Holders

            	
              9

            
	
              Section 1.5

            	
              Notices, etc., to Trustee and Company

            	
              10

            
	
              Section 1.6

            	
              Notice to Holders; Waiver

            	
              11

            
	
              Section 1.7

            	
              Conflict with Trust Indenture Act

            	
              11

            
	
              Section 1.8

            	
              Effect of Headings and Table of Contents

            	
              12

            
	
              Section 1.9

            	
              Benefits of Agreement

            	
              12

            
	
              Section 1.10

            	
              Governing Law

            	
              12

            
	
              Section 1.11

            	
              Legal Holidays

            	
              12

            
	
              Section 1.12

            	
              Separability Clause

            	
              13

            
	
              Section 1.13

            	
              No Recourse Against Others

            	
              13

            
	
              Section 1.14

            	
              Counterparts

            	
              13

            
	
              Section 1.15

            	
              Acceptance of Trust

            	
              13

            
	
              Section 1.16

            	
              Termination

            	
              13

            
	 	 	 
	
              Article 2 SECURITY FORMS

            	
              13

            
	
              Section 2.1

            	
              Forms Generally

            	
              13

            
	 	 	 
	
              Article 3 THE SECURITIES

            	
              14

            
	
              Section 3.1

            	
              Title and Terms

            	
              14

            
	
              Section 3.2

            	
              Registrable Form

            	
              15

            
	
              Section 3.3

            	
              Execution, Authentication, Delivery and Dating

            	
              15

            
	
              Section 3.4

            	
              [Intentionally Omitted]

            	
              16

            
	
              Section 3.5

            	
              Registration, Registration of Transfer and Exchange

            	
              16

            
	
              Section 3.6

            	
              Mutilated, Destroyed, Lost and Stolen Securities

            	
              19

            
	
              Section 3.7

            	
              Payments with respect to CVRs

            	
              19

            
	
              Section 3.8

            	
              Persons Deemed Owners

            	
              19

            
	
              Section 3.9

            	
              Cancellation

            	
              19

            
	
              Section 3.10

            	
              CUSIP Numbers

            	
              20

            
	 	 	 
	
              Article 4 THE TRUSTEE

            	
              20

            
	
              Section 4.1

            	
              Certain Duties and Responsibilities

            	
              20

            
	
              Section 4.2

            	
              Certain Rights of Trustee

            	
              21

            
	
              Section 4.3

            	
              Notice of Default

            	
              22

            
	
              Section 4.4

            	
              Not Responsible for Recitals or Issuance of Securities

            	
              22

            
	
              Section 4.5

            	
              May Hold Securities

            	
              22

            
	
              Section 4.6

            	
              Money Held in Trust

            	
              23

            
	
              Section 4.7

            	
              Compensation and Reimbursement

            	
              23

            
	
              Section 4.8

            	
              Disqualification; Conflicting Interests

            	
              23

            
	
              Section 4.9

            	
              Corporate Trustee Required; Eligibility

            	
              24

            
	
              Section 4.10

            	
              Resignation and Removal; Appointment of Successor

            	
              24

            

       

      
        i

        
          

      

      

      

      	
              Section 4.11

            	
              Acceptance of Appointment of Successor

            	
              25

            
	
              Section 4.12

            	
              Merger, Conversion, Consolidation or Succession to Business

            	
              26

            
	
              Section 4.13

            	
              Preferential Collection of Claims Against Company

            	
              26

            
	 	 	 
	
              Article 5 HOLDERS’ LISTS AND REPORTS BY THE TRUSTEE AND COMPANY

            	
              26

            
	
              Section 5.1

            	
              Company to Furnish Trustee Names and Addresses of Holders

            	
              26

            
	
              Section 5.2

            	
              Preservation of Information; Communications to Holders

            	
              26

            
	
              Section 5.3

            	
              Reports by Trustee

            	
              27

            
	
              Section 5.4

            	
              Reports by Company

            	
              27

            
	 	 	 
	
              Article 6 AMENDMENTS

            	
              28

            
	
              Section 6.1

            	
              Amendments Without Consent of Holders

            	
              28

            
	
              Section 6.2

            	
              Amendments with Consent of Holders

            	
              28

            
	
              Section 6.3

            	
              Execution of Amendments

            	
              29

            
	
              Section 6.4

            	
              Effect of Amendments; Notice to Holders

            	
              29

            
	
              Section 6.5

            	
              Conformity with Trust Indenture Act

            	
              30

            
	
              Section 6.6

            	
              Reference in Securities to Amendments

            	
              30

            
	 	 	 
	
              Article 7 COVENANTS

            	
              30

            
	
              Section 7.1

            	
              Payment of Amounts, if any, to Holders

            	
              30

            
	
              Section 7.2

            	
              Maintenance of Office or Agency

            	
              30

            
	
              Section 7.3

            	
              Money for Security Payments to Be Held in Trust

            	
              31

            
	
              Section 7.4

            	
              Certain Purchases and Sales

            	
              32

            
	
              Section 7.5

            	
              Books and Records

            	
              32

            
	
              Section 7.6

            	
              Listing of CVRs

            	
              32

            
	
              Section 7.7

            	
              Product Transfer

            	
              32

            
	
              Section 7.8

            	
              Diligent Efforts

            	
              32

            
	
              Section 7.9

            	
              Confidentiality

            	
              33

            
	
              Section 7.10

            	
              Non-Use of Name

            	
              33

            
	
              Section 7.11

            	
              Notice of Default

            	
              33

            
	 	 	 
	
              Article 8 REMEDIES OF THE TRUSTEE AND HOLDERS ON EVENT OF DEFAULT

            	
              34

            
	
              Section 8.1

            	
              Event of Default Defined; Waiver of Default

            	
              34

            
	
              Section 8.2

            	
              Collection by the Trustee; the Trustee May Prove Payment Obligations

            	
              35

            
	
              Section 8.3

            	
              Application of Proceeds

            	
              37

            
	
              Section 8.4

            	
              Suits for Enforcement

            	
              37

            
	
              Section 8.5

            	
              Restoration of Rights on Abandonment of Proceedings

            	
              37

            
	
              Section 8.6

            	
              Limitations on Suits by Holders

            	
              38

            
	
              Section 8.7

            	
              Unconditional Right of Holders to Institute Certain Suits

            	
              38

            
	
              Section 8.8

            	
              Powers and Remedies Cumulative; Delay or Omission Not Waiver of Default

            	
              38

            
	
              Section 8.9

            	
              Control by Holders

            	
              39

            
	
              Section 8.10

            	
              Waiver of Past Defaults

            	
              39

            

       

      
        ii

        
          

      

      

      

      	
              Section 8.11

            	
              The Trustee to Give Notice of Default, But May Withhold in Certain Circumstances

            	
              39

            
	
              Section 8.12

            	
              Right of Court to Require Filing of Undertaking to Pay Costs

            	
              40

            
	 	 	 
	
              Article 9 CONSOLIDATION, MERGER, SALE OR CONVEYANCE

            	
              40

            
	
              Section 9.1

            	
              Company May Consolidate, etc., on Certain Terms

            	
              40

            
	
              Section 9.2

            	
              Successor Person Substituted

            	
              40

            
	
              Section 9.3

            	
              Opinion of Counsel to the Trustee

            	
              41

            
	
              Section 9.4

            	
              Successors

            	
              41

            
	 	 	 
	
              Article 10 SUBORDINATION

            	
              41

            
	
              Section 10.1

            	
              Agreement to Subordinate

            	
              41

            
	
              Section 10.2

            	
              Liquidation; Dissolution; Bankruptcy

            	
              42

            
	
              Section 10.3

            	
              Default on Senior Obligations

            	
              42

            
	
              Section 10.4

            	
              When Distribution Must Be Paid Over

            	
              43

            
	
              Section 10.5

            	
              Notice by Company

            	
              43

            
	
              Section 10.6

            	
              Subordination Effective Notwithstanding Deficiencies with Respect to Senior Obligations: Waiver of Right to Contest Senior Obligation: Reinstatement
                  of Subordination Provisions

            	
              43

            
	
              Section 10.7

            	
              Subrogation

            	
              44

            
	
              Section 10.8

            	
              Relative Rights

            	
              44

            
	
              Section 10.9

            	
              Subordination May Not Be Impaired by Company

            	
              45

            
	
              Section 10.10

            	
              Distribution or Notice to Representative

            	
              45

            
	
              Section 10.11

            	
              Rights of the Trustee

            	
              45

            
	
              Section 10.12

            	
              Authorization to Effect Subordination

            	
              45

            
	
              Section 10.13

            	
              Amendments

            	
              45

            

      

      

      Annex A — Form of Global Security

      

      

      Note: This table of contents shall not, for any purpose, be deemed to be a part of this CVR Agreement.

       

      
        iii

        
          

      

      

      

      Reconciliation and tie between Trust Indenture Act of 1939 and Contingent Value Rights Agreement, dated as of [____], [___].

      

      

      	
              Trust Indenture Act Section

            	 	
              Agreement Section

            
	
              Section 310

            	
              (a)(1)

            	 	
              4.9

            
	 	
              (a)(2)

            	 	
              4.9

            
	 	
              (a)(3)

            	 	
              Not Applicable

            
	 	
              (a)(4)

            	 	
              Not Applicable

            
	 	
              (a)(5)

            	 	
              4.9

            
	 	
              (b)

            	 	
              4.8, 4.10

            
	 	
              (c)

            	 	
              Not Applicable

            
	 	 	 	 
	
              Section 311

            	
              (a)

            	 	
              4.13

            
	 	
              (b)

            	 	
              4.13

            
	 	
              (c)

            	 	
              Not Applicable

            
	 	 	 	 
	
              Section 312

            	
              (a)

            	 	
              5.1, 5.2(a)

            
	 	
              (b)

            	 	
              5.2(b)

            
	 	
              (c)

            	 	
              5.2(c)

            
	 	 	 	 
	
              Section 313

            	
              (a)

            	 	
              5.3(a)

            
	 	
              (b)

            	 	
              5.3(a)

            
	 	
              (c)

            	 	
              5.3(a), 8.11

            
	 	
              (d)

            	 	
              5.3(b)

            
	 	 	 	 
	
              Section 314

            	
              (a)

            	 	
              5.4, 7.11

            
	 	
              (b)

            	 	
              Not Applicable

            
	 	
              (c)(1)

            	 	
              1.2(a)

            
	 	
              (c)(2)

            	 	
              1.2(a)

            
	 	
              (c)(3)

            	 	
              Not Applicable

            
	 	
              (d)

            	 	
              Not Applicable

            
	 	
              (e)

            	 	
              1.2(b)

            
	 	
              (f)

            	 	
              Not Applicable

            
	 	 	 	 
	
              Section 315

            	
              (a)

            	 	
              4.1(a), 4.1(b)

            
	 	
              (b)

            	 	
              8.11

            
	 	
              (c)

            	 	
              4.1(a)

            
	 	
              (d)

            	 	
              4.1(c)

            
	 	
              (d)(1)

            	 	
              4.1(a), 4.1(b)

            
	 	
              (d)(2)

            	 	
              4.1(c)(ii)

            
	 	
              (d)(3)

            	 	
              4.1(c)(iii)

            
	 	
              (e)

            	 	
              8.12

            
	 	 	 	 
	
              Section 316

            	
              (a)(last sentence)

            	 	
              Not Applicable

            
	 	
              (a)(1)(A)

            	 	
              8.9

            
	 	
              (a)(1)(B)

            	 	
              8.10

            

       

      
        iv

        
          

      

      

      

      	
              Trust Indenture Act Section

            	 	
              Agreement Section

            
	 	
              (a)(2)

            	 	
              Not Applicable

            
	 	
              (b)

            	 	
              8.7

            
	 	
              (c)

            	 	
              Not Applicable

            
	 	 	 	 
	
              Section 317

            	
              (a)(1)

            	 	
              8.2

            
	 	
              (a)(2)

            	 	
              8.2

            
	 	
              (b)

            	 	
              7.3

            
	 	 	 	 
	
              Section 318

            	
              (a)

            	 	
              1.7

            

      

      

      Note: This reconciliation and tie shall not, for any purpose, be deemed to be a part of this CVR Agreement.

       

      
        v

        
          

      

      
      

      

      THIS CONTINGENT VALUE RIGHTS AGREEMENT, dated as of [_____], [____] (this “CVR
            Agreement”), by and between Bristol-Myers Squibb Company, a Delaware corporation (the “Company”), and [Trustee], a [______], as trustee (the “Trustee”), in favor of each person who from time to time holds one or more Contingent Value Rights (the “Securities”
        or “CVRs”) to receive cash payments in the amounts and subject to the terms and conditions set forth herein.

      

      

      WITNESSETH:

      

      

      WHEREAS, this CVR Agreement is entered into pursuant to the Agreement and Plan of Merger, dated as of January 3, 2019 (as amended,
          supplemented or otherwise modified in accordance with its terms, the “Merger Agreement”), by and among the Company, Burgundy Merger Sub, Inc., a Delaware corporation and
          wholly owned Subsidiary of the Company (“Merger Sub”), and Celgene Corporation, a Delaware corporation (“Celgene”);

      

      

      WHEREAS, pursuant to the Merger Agreement, Merger Sub will merge with and into Celgene (the “Merger”), with Celgene being the surviving corporation in the Merger and becoming a wholly-owned Subsidiary of the Company;

      

      

      WHEREAS, the CVRs shall be issued in accordance with and pursuant to the terms of the Merger Agreement; and

      

      

      WHEREAS, a registration statement on Form S-4 (No. 333-[_____]) with respect to the CVRs has been prepared and filed by the Company
          with the Commission (as defined below) and has become effective in accordance with the Securities Act of 1933, as amended.

      

      

      NOW, THEREFORE, in consideration of the foregoing premises and the consummation of the transactions contemplated by the Merger
          Agreement, it is covenanted and agreed, for the equal and proportionate benefit of all Holders of the Securities, as follows:

      

      

      ARTICLE 1

      DEFINITIONS AND OTHER PROVISIONS OF GENERAL APPLICATION

      

      

      Section 1.1           Definitions. For all purposes of this CVR Agreement, except as otherwise expressly provided or unless the context otherwise requires:

      

      

      (a)          the terms defined in this
          Article have the meanings assigned to them in this Article, and include the plural as well as the singular;

      

      

      (b)          all capitalized terms used in
          this CVR Agreement without definition shall have the respective meanings ascribed to them in the Merger Agreement;

      

      

      (c)          all other terms used herein
          which are defined in the Trust Indenture Act (as defined herein), either directly or by reference therein, have the respective meanings assigned to them therein;

       

      
        1

        
          

      

      
      

      

      (d)          the words “herein,” “hereof” and “hereunder”
          and other words of similar import refer to this CVR Agreement as a whole and not to any particular Article, Section or other subdivision; and

      

      

      (e)         whenever the words “include”, “includes” or “including”
          are used in this CVR Agreement, they shall be deemed to be followed by the words “without limitation”, whether or not they are in fact followed by those words or words
          of like import.

      

      

      “Affiliate” of any specified Person means any other
          Person directly or indirectly controlling or controlled by or under direct or indirect common control with such specified Person. For the purposes of this definition, “control” when used with respect to any specified Person means the power to
          direct the management and policies of such Person, directly or indirectly, whether through the ownership of voting securities, by contract or otherwise; and the terms “controlling” and “controlled” have meanings correlative to the foregoing.

      

      

      “Aggregate Milestone Payment” shall have the meaning set
          forth in Section 3.1(c) of this CVR Agreement.

      

      

      “Applicable Procedures” means, with respect to any
          transfer or exchange of or for beneficial interests in any Global Security, the rules and procedures of the Depositary that apply to such transfer or exchange.

      

      

      “BB2121” means a chimeric antigen receptor (“CAR”) T cell therapy targeting B-cell maturation antigen (BCMA).

      

      

      “BB2121 Milestone” means the first approval by the FDA of
          a biologic license application (BLA) that grants Celgene, the Company or any of their respective Affiliates (or their respective successors and assigns) the right to commercially manufacture, market and sell BB2121 in the United States in
          accordance with applicable Law for the treatment of relapsed/refractory multiple myeloma in humans.

      

      

      “BB2121 Milestone Target Date” means March 31, 2021.

      

      

      “Board of Directors” means the board of directors of the
          Company or any other body performing similar functions, or any duly authorized committee of that board.

      

      

      “Board Resolution” means a copy of a resolution certified
          by the chairman of the Board of Directors, the chief executive officer, the secretary or any assistant secretary of the Company, to have been duly adopted by the Board of Directors and to be in full force and effect on the date of such
          certification, and delivered to the Trustee.

      

      

      “Business Day” means any day (other than a Saturday or a
          Sunday) on which banking institutions in The City of New York, New York are not authorized or obligated by Law or executive order to close and, if the CVRs are listed on a national securities exchange, electronic trading network or other suitable
          trading platform, such exchange, electronic network or other trading platform is open for trading.

      

      

      “Code” means the U.S. Internal Revenue Code of 1986, as
          amended.

       

      
        2

        
          

      

      

      

      “Commission” means the Securities and Exchange
          Commission, as from time to time constituted, created under the Exchange Act (as defined herein), or if at any time after the execution of this instrument such Commission is not existing and performing the duties now assigned to it under the
          Trust Indenture Act, then the body performing such duties at such time.

      

      

      “Common Stock” shall have the meaning set forth in the
          Recitals of this CVR Agreement.

      

      

      “Company” means the Person (as defined herein) named as
          the “Company” in the first paragraph of this CVR Agreement, until a successor Person shall have become such pursuant to the applicable provisions of this CVR Agreement, and thereafter “Company” shall mean such successor Person. To the extent
          necessary to comply with the requirements of the provisions of Trust Indenture Act Sections 310 through 317, inclusive, to the extent that they are applicable to the Company, the term “Company” shall include any other obligor with respect to the
          Securities for the purposes of complying with such provisions.

      

      

      “Company Request” or “Company Order” means a written request or order signed in the name of the Company by the chairman of the Board of Directors, the chief executive officer, any President or Vice President, the
          secretary or any assistant secretary or any other individual duly authorized to act on behalf of the Company for such purpose or for any general purpose, and delivered to the Trustee.

      

      

      “Confidential Information” shall have the meaning set
          forth in Section 7.9 of this CVR Agreement.

      

      

      “Corporate Trust Office” means the office of the Trustee
          at which at any particular time its corporate trust business shall be principally administered, which office at the date of execution of this CVR Agreement is located at [________].

      

      

      “CVRs” shall have the meaning set forth in the Preamble
          of this CVR Agreement.

      

      

      “CVR Agreement” means this instrument as originally
          executed and as it may from time to time be supplemented or amended pursuant to the applicable provisions hereof.

      

      

      “Default Interest Rate” means a rate equal to the sum of
          three percent (3%) plus the prime rate of interest quoted in the Money Rates section of The Wall Street Journal (New York Edition), or similar reputable
          data source, calculated daily on the basis of a three hundred sixty-five (365) day year or, if lower, the highest rate permitted under applicable Law.

      

      

      “Depositary” shall have the meaning set forth in Section 3.2 of this CVR Agreement.

      

      

      “Diligent Efforts” means, with respect to any Product,
          efforts of a Person to carry out its obligations in a diligent manner using such effort and employing such resources normally used by such Person in the exercise of its reasonable business discretion relating to the research, development or
          commercialization of a product, that is of similar market potential at a similar stage in its development or product life, taking into account issues of market exclusivity (including patent coverage, regulatory and other exclusivity), safety and
          efficacy, product profile (including tolerability and convenience), the competitiveness of alternate products in the marketplace or under development, the launch or sales of one or
            more generic or biosimilar products, actual or likely pricing/reimbursement for the product, the likely timing of the product’s entry into the market, the likelihood of
            regulatory approval of the product and applicable labeling, and the profitability of the applicable product, and other relevant factors, including technical, commercial, legal, scientific, and/or medical factors, based on conditions
          then prevailing.

       

      
        3

        
          

      

      

      

      “Direct Registration Securities” means Securities, the
          ownership of which is recorded on the Direct Registration System. The terms “deliver,” “execute,” “issue,” “register,” “surrender,” “transfer” or “cancel,” when used with respect to Direct Registration Securities, shall refer to an entry or
          entries or an electronic transfer or transfers in the Direct Registration System.

      

      

      “Direct Registration System” means the system for the
          uncertificated registration of ownership of securities established by the Security Registrar and utilized by the Security Registrar pursuant to which the Security Registrar may record the ownership of CVRs without the issuance of a certificate,
          which ownership shall be evidenced by periodic statements issued by the Security Registrar to the Holders entitled thereto.

      

      

      “Event of Default” shall have the meaning set forth in Section 8.1 of this CVR Agreement.

      

      

      “Exchange Act” means the Securities Exchange Act of 1934,
          as amended.

      

      

      “Exchange Act Documents” shall have the meaning set forth
          in Section 5.4(a) of this CVR Agreement.

      

      

      “FDA” means the United States Food and Drug
          Administration or any successor agency.

      

      

      “Global Securities” means global securities in registered
          form, substantially in the form set forth in Annex A.

      

      

      “Governmental Entity” means any domestic (federal or
          state), or foreign court, commission, governmental body, regulatory or administrative agency or other political subdivision thereof.

      

      

      “Holder” means a Person in whose name a Security is
          registered in the Security Register.

      

      

      “Indirect Participant” means a Person who holds a
          beneficial interest in a Global Security through a Participant.

      

      

      “Initial Milestone Target Date” means December 31, 2020.

      

      

      “JCAR017” means a CAR T cell therapy targeting CD-19.

      

      

      “JCAR017 Milestone” means the first approval by the FDA
          of a biologic license application (BLA) that grants Celgene, the Company or any of their respective Affiliates (or their respective successors and assigns) the right to commercially manufacture, market and sell JCAR017 in the United States in
          accordance with applicable Law for the treatment of any relapsed-refractory diffuse large B cell lymphoma in humans.

       

      
        4

        
          

      

      

      

      “Junior Obligations” has the meaning set forth in Section 10.1.

      

      

      “Law” means any foreign, federal, state, local or municipal
          laws, rules, judgments orders, regulations, statutes, ordinances, codes, decisions, injunctions, orders, decrees or requirements of any Governmental Entity.

      

      

      “Majority Holders” means, at the time of determination,
          Holders of at least a majority of the Outstanding CVRs.

      

      

      “Merger” shall have the meaning set forth in the Recitals of
          this CVR Agreement.

      

      

      “Merger Agreement” shall have the meaning set forth in the
          Recitals of this CVR Agreement.

      

      

      “Merger Sub” shall have the meaning set forth in the
          Recitals of this CVR Agreement.

      

      

      “Milestone” means the satisfaction of all (but not less
          than all) of the following: (i) the BB2121 Milestone has occurred on or prior to the BB2121 Milestone Target Date; (ii) the JCAR017 Milestone has occurred on or prior to the Initial Milestone Target Date; and (iii) the Ozanimod Milestone has
          occurred on or prior to the Initial Milestone Target Date.

      

      

      “Milestone Payment” means nine dollars ($9.00) per CVR.

      

      

      “Milestone Payment Date” means, with respect to the
          Milestone, the date that is selected by the Company that is no later twenty (20) Business Days following the first date on which the Milestone is achieved.

      

      

      “Milestone Payment Record Date” shall have the meaning
          set forth in Section 3.1(c) of this CVR Agreement.

      

      

      “Officer’s Certificate” when used with respect to the
          Company means a certificate signed by the chairman of the Board of Directors, the chief executive officer, any President or Vice President, the secretary or any assistant secretary or any other individual authorized to act on behalf of the
          Company delivered to the Trustee.

      

      

      “Opinion of Counsel” means a written opinion of counsel, who
          may be counsel for the Company.

      

      

      “Outstanding” when used with respect to Securities means,
          as of the date of determination, all Securities theretofore authenticated, as applicable, and delivered under this CVR Agreement, except: (i) Securities theretofore cancelled by the Trustee or delivered to the Trustee for cancellation and (ii)
          Securities in exchange for or in lieu of which other Securities have been authenticated, as applicable, and delivered pursuant to this CVR Agreement, other than any such Securities in respect of which there shall have been presented to the
          Trustee proof satisfactory to it that such Securities are held by a bona fide purchaser in whose hands the Securities are valid obligations of the Company; provided, however, that in determining whether the Holders of the requisite Outstanding Securities have given any request, demand, direction, consent or waiver hereunder, Securities
          owned by the Company or any Affiliate of the Company, whether held as treasury securities or otherwise, shall be disregarded and deemed not to be Outstanding.

       

      
        5

        
          

      

      

      

      “Ozanimod” means a small molecule sphingosine 1-phosphate
          receptor modulator, which binds to sphingosine 1-phosphate receptors 1 and 5.

      

      

      “Ozanimod Milestone” means the first approval by the FDA
          of a new drug application (NDA) that grants Celgene, the Company or any of their respective Affiliates (or their respective successors and assigns) the right to commercially manufacture, market and sell Ozanimod in the United States in accordance
          with applicable Law for the treatment of relapsing multiple sclerosis in humans.

      

      

      “Participant” means, with respect to the Depositary, a
          Person who has an account with the Depositary.

      

      

      “Party” shall mean the Trustee, the Company and/or
          Holder(s), as applicable.

      

      

      “Paying Agent” means any Person authorized by the Company
          to pay the amount determined pursuant to Section 3.1, if any, on any Securities on behalf of the Company.

      

      

      “Person” means any individual, corporation, partnership,
          joint venture, association, joint-stock company, trust, limited liability company, unincorporated organization or government or any agency or political subdivision thereof.

      

      

      “President” when used with respect to the Company or the
          Trustee, means any president, whether or not designated by a number or a word or words added before or after the title of “president.”

      

      

      “Products” means each of (a) BB2121, (b) JCAR017 and (c)
          Ozanimod.

      

      

      “Representatives” shall have the meaning set forth in Section 7.9 of this CVR Agreement.

      

      

      “Responsible Officer” when used with respect to the
          Trustee means any officer assigned to the Corporate Trust Office and also means, with respect to any particular corporate trust matter, any other officer of the Trustee to whom such matter is referred because of his knowledge of and familiarity
          with the particular subject.

      

      

      “Securities” shall have the meaning set forth in the
          Preamble of this CVR Agreement.

      

      

      “Security Register” shall have the meaning set forth in Section 3.5(a) of this CVR Agreement.

      

      

      “Security Registrar” shall have the meaning set forth in
          Section 3.5(a) of this CVR Agreement.

       

      
        6

        
          

      

      

      

      “Senior Obligations” means any existing or future
          obligations of the Company, including the principal of, premium (if any), interest (including any interest accruing subsequent to the filing of a petition of bankruptcy at the rate provided for in the documentation with respect thereto, whether
          or not such interest is an allowed claim under applicable Law) on, and all other amounts owing thereon, (i) with respect to borrowed money, (ii) evidenced by notes, debentures, bonds or other similar debt instruments, (iii) with respect to the
          net obligations owed under interest rate swaps or similar agreements or currency exchange transactions, (iv) reimbursement obligations in respect of letters of credit and similar obligations, (v) in respect of capital leases, or (vi) guarantees
          in respect of obligations referred to in clauses (i) through (v) above; unless, in any case, the instrument creating or evidencing the same or pursuant to which the same is outstanding provides that such obligations are pari passu to or
          subordinate in right of payment to the Securities.

      

      

      Notwithstanding the foregoing, “Senior Obligations” shall not include:

      

      

      
        
          	

                	(A)	
                  Junior Obligations;

                

        

      

      

      

      
        
          	

                	(B)	
                  trade debt incurred in the ordinary course of business;

                

        

      

      

      

      
        
          	

                	(C)	
                  any intercompany indebtedness between the Company and any of its Subsidiaries or Affiliates;

                

        

      

      

      

      
        
          	

                	(D)	
                  indebtedness of the Company that is expressly subordinated in right of payment to Senior Obligations;

                

        

      

      

      

      
        
          	

                	(E)	
                  indebtedness or other obligations of the Company that by its terms ranks equal or junior in right of payment to the Junior Obligations;

                

        

      

      

      

      
        
          	

                	(F)	
                  indebtedness of the Company that, by operation of Law, is subordinate to any general unsecured obligations of the Company; or

                

        

      

      

      

      
        
          	

                	(G)	
                  indebtedness evidenced by any guarantee of indebtedness ranking equal or junior in right of payment to the Junior Obligations.

                

        

      

      

      

      “Subsidiary” means, with respect to any Person, any
          corporation, limited liability company, association, partnership or other business entity of which more than fifty percent (50%) of the total voting power of shares of Voting Securities is at the time owned or controlled, directly or indirectly,
          by: (i) such Person; (ii) such Person and one or more Subsidiaries of such Person; or (iii) one or more Subsidiaries of such Person.

      

      

      “Tax” means any federal, state, local or foreign income,
          profits, gross receipts, license, payroll, employment, severance, stamp, occupation, premium, windfall profits, environmental, customs duty, capital stock, franchise, sales, social security, unemployment, disability, use, property, withholding,
          excise, transfer, registration, production, value added, alternative minimum, occupancy, estimated or any other tax of any kind whatsoever, together with any interest, penalty or addition thereto, imposed by any Governmental Entity responsible
          for the imposition of any such tax, whether disputed or not.

       

      
        7

        
          

      

      

      

      “Tax Return” means any return, report, declaration, claim
          or other statement (including attached schedules) relating to Taxes.

      

      

      “Termination Date” shall have the meaning set forth in Section 1.16 of this CVR Agreement.

      

      

      “Trust Indenture Act” means the Trust Indenture Act of
          1939, as amended from time to time.

      

      

      “Trustee” means the Person named as the “Trustee” in the
          first paragraph of this CVR Agreement, until a successor Trustee shall have become such pursuant to the applicable provisions of this CVR Agreement, and thereafter “Trustee” shall mean such successor Trustee.

      

      

      “Vice President” when used with respect to the Company or
          the Trustee, means any vice president, whether or not designated by a number or a word or words added before or after the title of “vice president.”

      

      

      “Voting Securities” means securities or other interests
          having voting power, or the right, to elect or appoint a majority of the directors, or any Persons performing similar functions, irrespective of whether or not stock or other interests of any other class or classes shall have or might have voting
          power or any right by reason of the happening of any contingency.

      

      

      Section 1.2           Compliance and Opinions.

      

      

      (a)         Upon any application or request
          by the Company to the Trustee to take any action under any provision of this CVR Agreement, the Company shall furnish to the Trustee an Officers’ Certificate stating that, in the opinion of the signor, all conditions precedent, if any, provided
          for in this CVR Agreement relating to the proposed action have been complied with and an Opinion of Counsel stating, subject to customary exceptions, that in the opinion of such counsel all such conditions precedent, if any, have been complied
          with, except that, in the case of any such application or request as to which the furnishing of such documents is specifically required by any provision of this CVR Agreement relating to such particular application or request, no additional
          certificate or opinion need be furnished.

      

      

      (b)         Every certificate or opinion
          with respect to compliance with a condition or covenant provided for in this CVR Agreement shall include: (i) a statement that each individual signing such certificate or opinion has read such covenant or condition and the definitions herein
          relating thereto; (ii) a brief statement as to the nature and scope of the examination or investigation upon which the statements or opinions contained in such certificate or opinion are based; (iii) a statement that, in the opinion of each such
          individual, he or she has made such examination or investigation as is necessary to enable him to express an informed opinion as to whether or not such covenant or condition has been complied with; and (iv) a statement as to whether, in the
          opinion of each such individual, such condition or covenant has been complied with.

       

      
        8

        
          

      

      

      

      Section 1.3           Form of Documents Delivered to Trustee.

      

      

      (a)          In any case where several
          matters are required to be certified by, or covered by an opinion of, any specified Person, it is not necessary that all such matters be certified by, or covered by the opinion of, only one such Person, or that they be so certified or covered by
          only one document, but one such Person may certify or give an opinion with respect to some matters and one or more other such Persons as to other matters, and any such Person may certify or give an opinion as to such matters in one or several
          documents.

      

      

      (b)         Any certificate or opinion of an
          officer of the Company may be based, insofar as it relates to legal matters, upon a certificate or opinion of, or representations by, counsel. Any such certificate or Opinion of Counsel may be based, insofar as it relates to factual matters, upon
          a certificate or opinion of, or representations by, an officer or officers of the Company stating that the information with respect to such factual matters is in the possession of the Company.

      

      

      (c)         Any certificate, statement or
          opinion of an officer of the Company or of counsel may be based, insofar as it relates to accounting matters, upon a certificate or opinion of or representations by an accountant or firm of accountants in the employ of the Company. Any certificate or opinion of any independent firm of public accountants filed with the Trustee shall contain a statement that such firm is independent.

      

      

      (d)         Where any Person is required to
          make, give or execute two or more applications, requests, consents, certificates, statements, opinions or other instruments under this CVR Agreement, they may, but need not, be consolidated and form one instrument.

      

      

      Section 1.4           Acts of Holders.

      

      

      (a)        Any request, demand,
          authorization, direction, notice, consent, waiver or other action provided by this CVR Agreement to be given or taken by Holders may be embodied in and evidenced by one or more instruments of substantially similar tenor signed by such Holders in
          person or by an agent duly appointed in writing; and, except as herein otherwise expressly provided, such action shall become effective when such instrument or instruments are delivered to the Trustee and, where it is hereby expressly required,
          to the Company. Such instrument or instruments (and the action embodied therein and evidenced thereby) are herein sometimes referred to as the “Act” of the Holders
          signing such instrument or instruments. Proof of execution of any such instrument or of a writing appointing any such agent shall be sufficient for any purpose of this CVR Agreement and (subject to Section 4.1) conclusive in favor of the Trustee and the Company, if made in the manner provided in this Section 1.4. The Company may
          set a record date for purposes of determining the identity of Holders entitled to vote or consent to any action by vote or consent authorized or permitted under this CVR Agreement. If not previously set by the Company, (i) the record date for
          determining the Holders entitled to vote at a meeting of the Holders shall be the date preceding the date notice of such meeting is mailed to the Holders, or if notice is not given, on the day next preceding the day such meeting is held, and (ii)
          the record date for determining the Holders entitled to consent to any action in writing without a meeting shall be the first date on which a signed written consent setting forth the action taken or proposed to be taken is delivered to the
          Company. If a record date is fixed, those Persons who were Holders of Securities at such record date (or their duly designated proxies), and only those Persons, shall be entitled to take such action by vote or consent or, except with respect to
          clause (d) below, to revoke any vote or consent previously given, whether or not such Persons continue to be Holders after such record date. No such vote or consent shall be valid or effective for more than one hundred twenty (120) days after
          such record date.

       

      
        9

        
          

      

      

      

      (b)          The fact and date of the
          execution by any Person of any such instrument or writing may be proved in any reasonable manner which the Trustee deems sufficient.

      

      

      (c)          The ownership of Securities
          shall be proved by the Security Register. Neither the Company nor the Trustee nor any agent of the Company or the Trustee shall be affected by any notice to the contrary.

      

      

      (d)         At any time prior to (but not
          after) the evidencing to the Trustee, as provided in this Section 1.4, of the taking of any action by the Holders of the Securities specified in this CVR Agreement in
          connection with such action, any Holder of a Security the serial number of which is shown by the evidence to be included among the serial numbers of the Securities the Holders of which have consented to such action may, by filing written notice
          at the Corporate Trust Office and upon proof of holding as provided in this Section 1.4, revoke such action

            so far as concerns such Security. Any request, demand, authorization, direction, notice, consent, waiver or other action by the Holder of any Security shall bind every future Holder of the same Security or the Holder of every Security issued
            upon the registration of transfer thereof or in exchange therefor or in lieu thereof, in respect of anything done, suffered or omitted to be done by the Trustee, any Paying Agent or the Company in reliance thereon, whether or not notation of
            such action is made upon such Security.

      

      

      Section 1.5         Notices, etc., to Trustee and Company. Any request, demand, authorization, direction, notice, consent, waiver or Act of Holders or other document provided or permitted by this CVR Agreement to be made upon,
          given or furnished to, or filed with:

      

      

      (a)          the Trustee by any Holder or by
          the Company shall be sufficient for every purpose hereunder if made, given, furnished or filed, in writing, to or with the Trustee at its Corporate Trust Office; or

      

      

      (b)          the Company by the Trustee or
          by any Holder shall be sufficient for every purpose hereunder if in writing and mailed, first-class postage prepaid, to the Company addressed to it at:

      

      

      Bristol-Myers Squibb Company

      430 E. 29th Street, 14th Floor

      New York, New York 10016

       

      
        10

        
          

      

      

      

      Attn: Executive Vice President, General Counsel

      

      

      with copies to (which shall not constitute notice):

      

      

      Bristol-Myers Squibb Company

      Route 206 & Province Line Road

      Princeton, New Jersey 08540

      Attn: Senior Vice President and Deputy General Counsel, Transactional Practice Group

      

      

      and

      

      

      Kirkland & Ellis LLP

      601 Lexington Avenue

      New York, New York 10022

      
        
          	

                	Attn:	
                  David Fox, P.C.

                  Daniel Wolf, P.C.

                  Jonathan Davis, P.C. 

                

        

      

       

      or at any other address previously furnished in writing to the Trustee by the Company.

      

      

      Section 1.6          Notice to Holders; Waiver.

      

      

      (a)        Where this CVR Agreement provides
          for notice to Holders of any event, such notice shall be sufficiently given (unless otherwise herein expressly provided) if in writing and mailed, first-class postage prepaid, to each Holder affected by such event, at the Holder’s address as it
          appears in the Security Register, not later than the latest date, and not earlier than the earliest date, prescribed for the giving of such notice. In any case where notice to Holders is given by mail, neither the failure to mail such notice, nor
          any defect in any notice so mailed, to any particular Holder shall affect the sufficiency of such notice with respect to other Holders. Where this CVR Agreement provides for notice in any manner, such notice may be waived in writing by the Person
          entitled to receive such notice, either before or after the event, and such waiver shall be the equivalent of such notice. Waivers of notice by Holders shall be filed with the Trustee, but such filing shall not be a condition precedent to the
          validity of any action taken in reliance upon such waiver.

      

      

      (b)         In case by reason of the
          suspension of regular mail service or by reason of any other cause, it shall be impracticable to mail notice of any event as required by any provision of this CVR Agreement, then any method of giving such notice as shall be satisfactory to the
          Trustee shall be deemed to be a sufficient giving of such notice.

      

      

      Section 1.7          Conflict with Trust Indenture Act. If any provision hereof limits, qualifies or conflicts with another provision hereof which is required to be included in this CVR Agreement by any of the provisions of the
          Trust Indenture Act, such required provision shall control.

       

      
        11

        
          

      

      

      

      Section 1.8           Effect of Headings and Table of Contents. The Article and Section headings herein and the Table of Contents are for convenience only and shall not affect the construction hereof.

      

      

      Section 1.9          Benefits of Agreement. Nothing in this CVR Agreement or in the Securities, express or implied, shall give to any Person (other than the Parties hereto and their successors hereunder, any Paying Agent and the
          Holders) any benefit or any legal or equitable right, remedy or claim under this CVR Agreement or under any covenant or provision herein contained, all such covenants and provisions being for sole benefit of the Parties hereto and their
          successors, any Paying Agent and of the Holders.

      

      

      Section 1.10      Governing Law. THIS CVR AGREEMENT AND ALL SUITS, ACTIONS, PROCEEDINGS, CLAIMS AND CAUSES OF ACTION (WHETHER IN CONTRACT OR TORT) BASED UPON, ARISING OUT OF OR RELATING TO THIS CVR AGREEMENT, THE NEGOTIATION,
          EXECUTION OR PERFORMANCE OF THIS CVR AGREEMENT OR THE SECURITIES, SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK INCLUDING SECTIONS 5-1401 AND 5-1402 OF THE NEW YORK GENERAL OBLIGATIONS LAW WITHOUT REGARD
          TO THE CONFLICT OF LAWS PRINCIPLES THEREOF. EACH OF THE COMPANY, THE TRUSTEE AND EACH OF THE HOLDERS BY THEIR ACCEPTANCE OF THE SECURITIES, HEREBY IRREVOCABLY SUBMITS TO THE EXCLUSIVE JURISDICTION OF ANY NEW YORK STATE COURT SITTING IN THE
          BOROUGH OF MANHATTAN IN THE CITY OF NEW YORK OR ANY FEDERAL COURT SITTING IN THE BOROUGH OF MANHATTAN IN THE CITY OF NEW YORK IN RESPECT OF ANY SUIT, ACTION, PROCEEDING, CLAIM OR CAUSE OF ACTION (WHETHER IN CONTRACT OR TORT) BASED UPON, ARISING
          OUT OF OR RELATING TO THIS CVR AGREEMENT, THE NEGOTIATION, EXECUTION OR PERFORMANCE OF THIS CVR AGREEMENT OR THE SECURITIES, AND IRREVOCABLY ACCEPTS FOR ITSELF AND IN RESPECT OF ITS PROPERTY, GENERALLY AND UNCONDITIONALLY, JURISDICTION OF THE
          AFORESAID COURTS. EACH OF THE COMPANY AND THE TRUSTEE AGREES THAT PROCESS MAY BE SERVED UPON THEM IN ANY MANNER AUTHORIZED BY THE LAWS OF THE STATE OF NEW YORK FOR SUCH PERSONS AND IRREVOCABLY WAIVES, TO THE FULLEST EXTENT IT MAY EFFECTIVELY DO
          SO UNDER APPLICABLE LAW, ANY OBJECTION IT MAY NOW OR HEREAFTER HAVE TO SUCH SERVICE OF PROCESS, THE LAYING OF THE VENUE OF ANY SUCH SUIT, ACTION OR PROCEEDING BROUGHT IN ANY SUCH COURT AND ANY CLAIM THAT ANY SUCH SUIT, ACTION OR PROCEEDING
          BROUGHT IN ANY SUCH COURT HAS BEEN BROUGHT IN AN INCONVENIENT FORUM.

      

      

      Section 1.11         Legal Holidays. In the event that the Milestone Payment Date shall not be a Business Day, then (notwithstanding any provision of this CVR Agreement or the Securities to the contrary) payment on the Securities
          need not be made on such date, but may be made, without the accrual of any interest thereon, on the next succeeding Business Day with the same force and effect as if made on the Milestone Payment Date.

       

      
        12

        
          

      

      

      

      Section 1.12        Separability Clause. In case any provision in this CVR Agreement or in the CVRs shall be invalid, illegal or unenforceable, the validity, legality and enforceability of the remaining provisions shall not in any
          way be affected or impaired thereby.

      

      

      Section 1.13        No Recourse Against Others. A director, officer, employee, agent or representative of the Company or any Affiliate of the Company or the Trustee shall not have any liability for any obligations of the Company
          or the Trustee under the Securities or this CVR Agreement or for any claim based on, in respect of or by reason of such obligations or their creation. By accepting a Security each
            Holder waives and releases all such liability and all such claims. The waiver and release are part of the consideration for the issue of the Securities.

      

      

      Section 1.14        Counterparts. This CVR Agreement shall be signed in any number of counterparts with the same effect as if the signatures to each counterpart were upon a single instrument, and all such counterparts together
          shall be deemed an original of this CVR Agreement.

      

      

      Section 1.15         Acceptance of Trust. [________], the Trustee named herein, hereby accepts the trusts in this CVR Agreement declared and provided, upon the terms and conditions set forth herein.

      

      

      Section 1.16         Termination. This CVR Agreement will, automatically and without any further action of any Party, terminate and be of no force or effect, and the Parties hereto shall have no liability or obligations hereunder,
          at the following time (the “Termination Date”): (a) if as of the end of the day on the Initial Milestone Target Date, either the JCAR017 Milestone or the Ozanimod
          Milestone has not occurred, 12:01 a.m. New York City time on the calendar day following the Initial Milestone Target Date, (b) if both the JCAR017 Milestone and the Ozanimod Milestone have occurred on or prior to the Initial Milestone Target Date
          but, as of the end of the day on the BB2121 Milestone Target Date, the BB2121 Milestone has not occurred, 12:01 a.m. New York City time on the calendar day following the BB2121 Milestone Target Date or (c) if the Milestone has been achieved, the
          calendar day following the date on which the Trustee has paid the Milestone Payment to the Holders in accordance with Section 3.1(c); provided, however, that (A) Sections 1.5,
          1.6, 1.7, 1.8,
          1.9, 1.10, 1.12,
          1.13, 4.7, 7.5,
          7.9, 7.10, Article 8,
          this Section 1.16 and Section 1.1 (to the extent related to the foregoing) shall survive
          termination of this CVR Agreement in accordance with their terms; and (B) the termination of this Agreement shall not relieve any Party of any liability arising from any material breach of its obligations under this CVR Agreement occurring prior
          to the Termination Date.

      

      

      ARTICLE 2

      SECURITY FORMS

      

      

      Section 2.1           Forms Generally.

      

      

      (a)         (i) The Global Securities and
          the Trustee’s certificate of authentication shall be in substantially the forms set forth in Annex A, attached hereto and incorporated herein by this reference, with
          such appropriate insertions, omissions, substitutions and other variations as are required or permitted by this CVR Agreement and may have such letters, numbers or other marks of identification and such legends or endorsements placed thereon as
          may be required to comply with the rules of any securities exchange or as may be required by Law or any rule or regulation pursuant thereto, all as may be determined by the officers executing such Global Securities, as evidenced by their
          execution of the Global Securities. Any portion of the text of any Global Security may be set forth on the reverse thereof, with an appropriate reference thereto on the face of the Global Security.

       

      
        13

        
          

      

      

      

      (ii)         The Global Securities shall be
          typewritten, printed, lithographed or engraved on steel engraved borders or produced by any combination of these methods or may be produced in any other manner permitted by the rules of any securities exchange on which the Securities may be
          listed, all as determined by the officers executing such Global Securities, as evidenced by their execution of such Global Securities.

      

      

      (b)         The Direct Registration
          Securities shall be uncertificated and shall be evidenced by the Direct Registration System maintained by the Security Registrar.

      

      

      ARTICLE 3

      THE SECURITIES

      

      

      Section 3.1           Title and Terms.

      

      

      (a)          The aggregate number of CVRs
          which may be authenticated, as applicable, and delivered under this CVR Agreement is limited to a number equal to [_____], except for Securities authenticated, as applicable, and delivered upon registration of transfer of, or in exchange for, or
          in lieu of, other Securities pursuant to Section 3.5, 3.6 or 6.6. From and after the Merger Effective Time, the
            Company shall not be permitted to issue any CVRs that have the right to receive any portion of the Milestone Payment, except as provided and in accordance with the terms and conditions of the Merger Agreement.

      

      

      (b)          The Securities shall be known
          and designated as the “Series B Contingent Value Rights” of the Company.

      

      

      (c)          If the Milestone is achieved,
          then, on or prior to the Milestone Payment Date, the Company shall pay, or cause to be paid, to the Trustee, by wire transfer to the account designated in writing by the Trustee, an amount equal to the product of (A) the Milestone Payment, multiplied by (B) the number of Securities Outstanding as of such time (the “Aggregate Milestone Payment”),

          and the Trustee shall promptly (and in any event within two (2) Business Days of the receipt of the Aggregate Milestone Payment from the Company) pay to each Holder of record of the Securities as of 5:00 p.m. New York City time, three (3)
          Business Days prior to the Milestone Payment Date (the “Milestone Payment Record Date”) an amount equal to the product of (x) the Milestone Payment, multiplied by (y) the number of Securities held of record by such Holder as of the Milestone Payment Record Date. Subject to Section 1.16, the Company’s obligations to pay the Milestone Payment shall terminate in its entirety on the Termination Date.

      

      

      (d)          The Holders of the CVRs, by
          acceptance thereof, agree that no joint venture, partnership or other fiduciary relationship is created hereby or by the Securities.

       

      
        14

        
          

      

      

      

      (e)          Other than in the case of
          interest on amounts due and payable after the occurrence of an Event of Default, no interest or dividends shall accrue on any amounts payable in respect of the CVRs.

      

      

      (f)         The Parties hereto agree to
          treat the CVRs for all Tax purposes as additional consideration for the shares of Common Stock, the Company Stock Options, the Company RSU Awards, the Company PSU Awards and Company RSAs, as applicable, pursuant to the Merger Agreement, and none
          of the Parties hereto will take any position to the contrary on any Tax Return or for other Tax purposes except as otherwise required by applicable Law. The Company shall report imputed interest on the CVRs pursuant to Section 483 of the Code,
          except as otherwise required by applicable Law.

      

      

      (g)         The CVRs and any interest
          thereon may be sold, assigned, pledged encumbered or in any manner transferred or disposed of, in whole or in part, only in compliance with applicable United States federal and state securities Laws and, to the extent applicable, in accordance
          with Section 3.5.

      

      

      (h)         The Holder of any CVR is not,
          and shall not, by virtue thereof, be entitled to any rights of a holder of any Voting Securities or other equity security or other ownership interest of the Company, in any constituent company to the Merger or in any of their respective
          Affiliates, either at Law or in equity, and the rights of the Holders are limited to those contractual rights expressed in this CVR Agreement.

      

      

      (i)          Except as provided in this CVR
          Agreement, none of the Company or any of its Affiliates shall have any right to set-off any amounts owed or claimed to be owed by any Holder to any of them against such Holder’s Securities or the Milestone Payment or other amount payable to such
          Holder in respect of such Securities.

      

      

      Section 3.2         Registrable Form. The Securities shall be issuable only in registered form. The CVRs shall be issued initially in the form of (a) one or more permanent Global Securities, deposited with the Trustee, as the
          custodian for The Depository Trust Company, its nominees and successors (the “Depositary”), or (b) one or more Direct Registration Securities. Each Global Security will
          represent such of the outstanding CVRs as will be specified therein and each shall provide that it represents the aggregate number of outstanding CVRs from time to time endorsed thereon and that the aggregate number of outstanding CVRs
          represented thereby may from time to time be reduced or increased, as appropriate, to reflect exchanges and/or issuances as provided and in accordance with the terms and conditions of the Merger Agreement.

      

      

      Section 3.3           Execution, Authentication, Delivery and Dating.

      

      

      (a)          The Global Securities shall be
          executed on behalf of the Company by its chairman of the Board of Directors, its chief executive officer, any President or Vice President or any other individual duly authorized to act on behalf of the Company for such purpose or any general
          purpose, but need not be attested. The signature of any of these individuals on the Global Securities may be manual or facsimile.

       

      
        15

        
          

      

      

      

      (b)         Global Securities bearing the
          manual or facsimile signatures of individuals who were, at the time of execution, the proper officers of the Company shall bind the Company, notwithstanding that such individuals or any of them have ceased to hold such offices prior to the
          authentication and delivery of such Global Securities or did not hold such offices at the date of such Global Securities.

      

      

      (c)        At any time and from time to time
          after the execution and delivery of this CVR Agreement, the Company may deliver a Company Order for the authentication, as applicable, and delivery of Securities, and the Trustee, in accordance with such Company Order, shall authenticate, as
          applicable, and deliver such Securities as provided in this CVR Agreement and not otherwise. In the case of Global Securities, such Company Order shall be accompanied by Global Securities executed by the Company and delivered to the Trustee for
          authentication in accordance with such Company Order.

      

      

      (d)          Each Global Security shall be
          dated the date of its authentication.

      

      

      (e)         No Global Security shall be
          entitled to any benefit under this CVR Agreement or be valid or obligatory for any purpose unless there appears on such Security a certificate of authentication substantially in the form provided for herein duly executed by the Trustee, by manual
          or facsimile signature of an authorized officer, and such certificate upon any Security shall be conclusive evidence, and the only evidence, that such Global Security has been duly authenticated and delivered hereunder and that the Holder is
          entitled to the benefits of this CVR Agreement.

      

      

      (f)          Direct Registration Securities
          need not be authenticated, and shall be valid and obligatory for all purposes and shall entitle each Holder thereof to all benefits of this CVR Agreement.

      

      

      Section 3.4           [Intentionally Omitted].

      

      

      Section 3.5           Registration, Registration of Transfer and Exchange.

      

      

      (a)         The Company shall cause to be
          kept at the office of the Trustee a register (the register maintained in such office and in any other office or agency designated pursuant to Section 7.2 being herein
          sometimes referred to as the “Security Register”) in which, subject to such reasonable regulations as it may prescribe, the Company shall provide for the registration of
          Securities and of transfers of Securities. The Trustee is hereby initially appointed “Security Registrar” for the purpose of registering Securities and transfers of
          Securities as herein provided.

      

      

      (b)          (i) A Global Security may not
          be transferred except as a whole by the Depositary to a nominee of the Depositary, by a nominee of the Depositary to the Depositary or to another nominee of the Depositary, or by the Depositary or any such nominee to a successor Depositary or a
          nominee of such successor Depositary. All Global Securities will be exchanged by the Company for Direct Registration Securities if (1) the Company delivers to the Security Registrar notice from the Depositary that it is unwilling or unable to
          continue to act as Depositary or that it is no longer a clearing agency registered under the Exchange Act and, in either case, a successor Depositary is not appointed by the Company within 120 days after the date of such notice from the
          Depositary, (2) the Company in its sole discretion determines that the Global Securities (in whole but not in part) should be exchanged for Direct Registration Securities and delivers a written notice to such effect to the Security Registrar or
          (3) an Event of Default has occurred and is continuing and the Security Registrar has received a request from the Depositary to issue Direct Registration Securities. Upon the occurrence of either of the preceding events in (1) or (2) above,
          Direct Registration Securities shall be issued in such names as the Depositary shall instruct the Trustee. Global Securities also may be exchanged or replaced, in whole or in part, as provided in Section 3.6 hereof. Every Global Security authenticated and delivered in exchange for, or in lieu of, a Global Security or any portion thereof, pursuant to this Sections 3.5 or 3.6 hereof, shall be authenticated and delivered in the form of, and shall be, a Global Security. A Global Security may not be
          exchanged for another Global Security other than as provided in this Section 3.5(b)(i), however, beneficial interests in a Global Security may be transferred and
          exchanged as provided in Section 3.5(b)(ii) or (iii) hereof.

       

      
        16

        
          

      

      

      

      (ii)        The transfer and exchange of
          beneficial interests in the Global Securities will be effected through the Depositary, in accordance with the provisions of this CVR Agreement and the Applicable Procedures.
            Beneficial interests in any Global Security may be transferred to Persons who take delivery thereof in the form of a beneficial interest in Global Security. No written orders or instructions shall be required to be delivered to the Security
            Registrar to effect the transfers described in this Section 3.5(b)(ii).

      

      

      (iii)        If any holder of a beneficial
          interest in a Global Security proposes to exchange such beneficial interest for a Direct Registration Security or to transfer such beneficial interest to a Person who takes delivery thereof in the form of a Direct Registration Security, then the
          Security Registrar will cause the aggregate number of CVRs represented by the applicable Global Security to be reduced accordingly pursuant to Section 3.5(b)(vi)
          hereof, and the Security Registrar will deliver to the Person designated in the instructions a Direct Registration Security in the appropriate number of CVRs. Any Direct Registration Security issued in exchange for a beneficial interest pursuant
          to this Section 3.5(b)(iii) will be registered in such name or names and in such authorized denomination or denominations as the holder of such beneficial interest
          requests through instructions to the Security Registrar from or through the Depositary and the Participant or Indirect Participant.

      

      

      (iv)        A Holder of a Direct
          Registration Security may exchange such Direct Registration Security for a beneficial interest in a Global Security or transfer such Direct Registration Security to a Person who takes delivery thereof in the form of a beneficial interest in a
          Global Security at any time. Upon receipt of a request for such an exchange or transfer, the Security Registrar will cancel the applicable Direct Registration Security and increase or cause to be increased the aggregate number of CVRs represented
          by one of the Global Securities.

       

      
        17

        
          

      

      

      

      (v)         Upon request by a Holder of
          Direct Registration Securities and such Holder’s compliance with the provisions of this Section 3.5(b)(v), the Security Registrar will register the transfer or
          exchange of Direct Registration Securities. Prior to such registration of transfer or exchange, the requesting Holder must present to the Security Registrar a written instruction of transfer in form satisfactory to the Security Registrar duly
          executed by such Holder or by its attorney, duly authorized in writing. A Holder of Direct Registration Securities may transfer such Direct Registration Securities to a Person who takes delivery thereof in the form of Direct Registration
          Securities. Upon receipt of a request to register such a transfer, the Security Registrar shall register the Direct Registration Securities pursuant to the instructions from the Holder thereof.

      

      

      (vi)         At such time as all beneficial
          interests in a particular Global Security have been exchanged for Direct Registration Securities or a particular Global Security has been repurchased or canceled in whole and not in part, each such Global Security will be returned to or retained
          and canceled by the Security Registrar in accordance with Section 3.9 hereof. At any time prior to such cancellation, if any beneficial interest in a Global Security is
          exchanged for or transferred to a Person who will take delivery thereof in the form of a beneficial interest in another Global Security or for Direct Registration Securities, the aggregate number of CVRs represented by such Global Security will
          be reduced accordingly and an endorsement will be made on such Global Security by the Security Registrar or by the Depositary at the direction of the Security Registrar to reflect such reduction; and if the beneficial interest is being exchanged
          for or transferred to a Person who will take delivery thereof in the form of a beneficial interest in another Global Security, such other Global Security will be increased accordingly and an endorsement will be made on such Global Security by the Security Registrar or by the Depositary at the direction of the Security Registrar to reflect such increase.

      

      

      (vii)       (A) To permit registrations of
          transfers and exchanges, the Company will execute and the Trustee will authenticate Global Securities upon receipt of a Company Order in accordance with Section 3.3
          hereof or at the Security Registrar’s request.

      

      

      (B)           No service charge will be made
          to a Holder of a beneficial interest in a Global Security or to a Holder of a Direct Registration Security for any registration of transfer or exchange, but the Company may require payment of a sum sufficient to cover any transfer tax or similar
          governmental charge payable in connection therewith.

      

      

      (C)          All Global Securities and
          Direct Registration Securities issued upon any registration of transfer or exchange of Global Securities or Direct Registration Securities will be the valid obligations of the Company, evidencing the same rights, and entitled to the same benefits
          under this CVR Agreement, as the Global Securities or Direct Registration Securities surrendered upon such registration of transfer or exchange.

       

      
        18

        
          

      

      

      

      (D)           The Trustee will authenticate
          Global Securities in accordance with the provisions of Section 3.3 hereof.

      

      

      Section 3.6           Mutilated, Destroyed, Lost and Stolen Securities.

      

      

      (a)        If (i) any mutilated Global
          Security is surrendered to the Trustee, or (ii) the Company and the Trustee receive evidence to their satisfaction of the destruction, loss or theft of any Global Security, and there is delivered to the Company and the Trustee such security or
          indemnity as may be required by them to save each of them harmless, then, in the absence of notice to the Company or the Trustee that such Global Security has been acquired by a bona fide purchaser, the Company shall execute and, upon delivery of
          a Company Order, the Trustee shall authenticate, as applicable, and deliver, in exchange for any such mutilated Global Security or in lieu of any such destroyed, lost or stolen Global Security, a new CVR, in the form of either a Global Security
          or a Direct Registration Security, of like tenor and amount of CVRs, bearing a number not contemporaneously outstanding.

      

      

      (b)         In case any such mutilated,
          destroyed, lost or stolen Global Security has become or is to become finally due and payable within fifteen (15) days, the Company in its discretion may, instead of issuing a new CVR, pay to the Holder of such Security on the Milestone Payment
          Date all amounts due and payable with respect thereto.

      

      

      (c)         Every new Security issued
          pursuant to this Section 3.6 in lieu of any destroyed, lost or stolen Global Security shall constitute an original additional contractual obligation of the Company,
          whether or not the destroyed, lost or stolen Global Security shall be at any time enforceable by anyone, and shall be entitled to all benefits of this CVR Agreement equally and proportionately with any and all other Securities duly issued
          hereunder.

      

      

      (d)         The provisions of this Section 3.6 are exclusive and shall preclude (to the extent lawful) all other rights and remedies with respect to the replacement or payment of mutilated, destroyed, lost or
          stolen Global Securities.

      

      

      Section 3.7           Payments with respect to CVRs. Payment of any amounts pursuant to the CVRs shall be made in such coin or currency of the United States of America as at the time is legal tender for the payment of public and
          private debts. The Company may, at its option, pay such amounts by wire transfer or check payable in such money.

      

      

      Section 3.8          Persons Deemed Owners. Prior to the time of due presentment for registration of transfer, the Company, the Trustee and any agent of the Company or the Trustee may treat the Person in whose name any Security is
          registered as the owner of such Security for the purpose of receiving payment on such Security and for all other purposes whatsoever, whether or not such Security be overdue, and neither the Company, the Trustee nor any agent of the Company or
          the Trustee shall be affected by notice to the contrary.

      

      

      Section 3.9          Cancellation. All Securities surrendered for payment, registration of transfer or exchange shall, if surrendered to any Person other than the Trustee, be delivered to the Trustee and shall be promptly canceled
          by it. The Company may at any time deliver to the Trustee for cancellation any Global Securities previously authenticated and delivered hereunder which the Company may have acquired in any manner whatsoever, and all Global Securities so delivered
          shall be promptly canceled by the Trustee. No Securities shall be authenticated in lieu of or in exchange for any Securities canceled as provided in this Section, except as expressly permitted by this CVR Agreement. All cancelled Global
          Securities held by the Trustee shall be destroyed and a certificate of destruction shall be issued by the Trustee to the Company, unless otherwise directed by a Company Order.

       

      
        19

        
          

      

      

      

      Section 3.10        CUSIP Numbers. The Company in issuing the CVRs may use “CUSIP” numbers (if then generally in use), and, if so, the Trustee shall use “CUSIP” numbers in notices to the Holders as a convenience to the Holders;
          provided that any such notice may state that no representation is made as to the correctness of such numbers either as printed on the CVRs or as contained in any notices and that reliance may be placed only on the other identification numbers
          printed on the CVRs, and any such notice shall not be affected by any defect in or omission of such numbers. The Company will promptly notify the Trustee of any change in the “CUSIP” numbers.

      

      

      ARTICLE 4

      THE TRUSTEE

      

      

      Section 4.1           Certain Duties and Responsibilities.

      

      

      (a)         With respect to the Holders, the
          Trustee, prior to the occurrence of an Event of Default (as defined in Section 8.1) with respect to the Securities and after the curing or waiving of all Events of
          Default which may have occurred, undertakes to perform such duties and only such duties as are specifically set forth in this CVR Agreement and no implied covenants shall be read into this CVR Agreement against the Trustee. In case an Event of
          Default with respect to the Securities has occurred (which has not been cured or waived), the Trustee shall exercise such of the rights and powers vested in it by this CVR Agreement, and use the same degree of care and skill in their exercise, as
          a reasonably prudent person would exercise or use under the circumstances in the conduct of his or her own affairs.

      

      

      (b)         In the absence of bad faith on
          its part, prior to the occurrence of an Event of Default and after the curing or waiving of all such Events of Default which may have occurred, the Trustee may conclusively rely, as to the truth of the statements and the correctness of the
          opinions expressed therein, upon certificates or opinions furnished to the Trustee which conform to the requirements of this CVR Agreement; but in the case of any such certificates or opinions which by any provision hereof are specifically
          required to be furnished to the Trustee, the Trustee shall be under a duty to examine the same to determine whether or not they conform to the requirements of this CVR Agreement.

      

      

      (c)          No provision of this CVR
          Agreement shall be construed to relieve the Trustee from liability for its own negligent action, its own negligent failure to act, or its own willful misconduct, except that (i) this Subsection (c) shall not be construed to limit the effect of
          Subsections (a) and (b) of this Section 4.1; (ii) the Trustee shall not be liable for any error of judgment made in good faith by a Responsible Officer, unless it shall
          be proved that the Trustee was negligent in ascertaining the pertinent facts; and (iii) the Trustee shall not be liable with respect to any action taken or omitted to be taken by it in good faith in accordance with the direction of the Holders
          pursuant to Section 8.9 relating to the time, method and place of conducting any proceeding for any remedy available to the Trustee, or exercising any trust or power
          conferred upon the Trustee, under this CVR Agreement.

       

      
        20

        
          

      

      

      

      (d)         Whether or not therein expressly
          so provided, every provision of this CVR Agreement relating to the conduct or affecting the liability of or affording protection to the Trustee shall be subject to the provisions of this Section 4.1.

      

      

      Section 4.2           Certain Rights of Trustee. Subject to the provisions of Section 4.1, including the duty of care that the Trustee is required to
          exercise upon the occurrence of an Event of Default:

      

      

      (a)          the Trustee may rely and shall
          be protected in acting or refraining from acting upon any resolution, certificate, statement, instrument, opinion, report, notice, request, direction, consent, order, bond, debenture, note, other evidence of indebtedness or other paper or
          document reasonably believed by it to be genuine and to have been signed or presented by the proper party or parties and the Trustee need not investigate any fact or matter stated in the document;

      

      

      (b)         any request or direction or
          order of the Company mentioned herein shall be sufficiently evidenced by a Company Request or Company Order and any resolution of the Board of Directors may be sufficiently evidenced by a Board Resolution and the Trustee shall not be liable for
          any action it takes or omits to take in good faith reliance thereon;

      

      

      (c)         whenever in the administration
          of this CVR Agreement the Trustee shall deem it desirable that a matter be proved or established prior to taking, suffering or omitting any action hereunder, the Trustee (unless other evidence be herein specifically prescribed) may, in the
          absence of bad faith on its part, rely upon an Officers’ Certificate and the Trustee shall not be liable for any action it takes or omits to take in good faith reliance thereon or an Opinion of Counsel;

      

      

      (d)         the Trustee may consult with
          counsel and the written advice of such counsel or any Opinion of Counsel shall be full and complete authorization and protection in respect of any action taken, suffered or omitted by it hereunder in good faith and in accordance with such advice
          or Opinion of Counsel;

      

      

      (e)          the Trustee shall be under no
          obligation to exercise any of the rights or powers vested in it by this CVR Agreement at the request or direction of any of the Holders pursuant to this CVR Agreement, unless such Holders shall have offered to the Trustee reasonable security or
          indemnity against the costs, expenses and liabilities which might be incurred by it in compliance with such request or direction;

      

      

      (f)          the Trustee shall not be bound
          to make any investigation into the facts or matters stated in any resolution, certificate, statement, instrument, opinion, report, notice, request, consent, order, approval, appraisal, bond, debenture, note, coupon, security, or other paper or
          document, but the Trustee in its discretion may make such further inquiry or investigation into such facts or matters as it may see fit, and if the Trustee shall determine to make such further inquiry or investigation, it shall be entitled to
          examine the pertinent books and records of the Company, personally or by agent or attorney, as may be reasonably necessary for such inquiry or investigation and in a manner so as to not unreasonably interfere with the normal business operations
          of the Company or any of its Affiliates; provided, however, that Company shall not be
          required to provide any books or records to the extent that the provision thereof (i) would, as reasonably determined based on the advice of outside counsel, jeopardize any attorney-client privilege or (ii) would contravene any Law or any
          contract or agreement to which the Company or any of its Affiliates is subject or bound;

       

      
        21

        
          

      

      

      

      (g)         the Trustee may execute any of
          the trusts or powers hereunder or perform any duties hereunder either directly or by or through agents or attorneys and the Trustee shall not be responsible for any misconduct or negligence on the part of any agent or attorney appointed with due
          care by it hereunder;

      

      

      (h)        the Trustee shall not be liable
          for any action taken, suffered or omitted to be taken by it in good faith and reasonably believed by it to be authorized or within the discretion or rights or powers conferred upon it by this CVR Agreement; and

      

      

      (i)          the Trustee shall not be deemed
          to have notice of any default or Event of Default unless a Responsible Officer of the Trustee has actual knowledge thereof or unless written notice thereof has been received by such Responsible Officer at the offices of the Trustee and such
          notice references the CVRs and this CVR Agreement and the fact that such notice constitutes notification of default.

      

      

      Section 4.3          Notice of Default. If a default occurs hereunder with respect to the Securities, the Trustee shall give the Holders notice of any such default actually known to it as and to the extent applicable and provided
          by the Trust Indenture Act; provided, however, that in the case of any default of the
          character specified in Section 8.1(b) with respect to the Securities, no notice to Holders shall be given until at least thirty (30) days after the occurrence thereof.
          For the purpose of this Section 4.3, the term “default” means any event that is, or after notice or lapse of time or both would become, an Event of Default with respect
          to the Securities.

      

      

      Section 4.4        Not Responsible for Recitals or Issuance of Securities. The Trustee shall not be accountable for the Company’s use of the Securities. The recitals contained herein and in the Securities, except the Trustee’s
          certificates of authentication, shall be taken as the statements of the Company, and the Trustee assumes no responsibility for their correctness. The Trustee makes no representations
            as to the validity or sufficiency of this CVR Agreement or of the Securities.

      

      

      Section 4.5          May Hold Securities. The Trustee, any Paying Agent, Security Registrar or any other agent of the Company, in its individual or any other capacity, may become the owner or pledgee of Securities, and, subject to
          Sections 4.8 and 4.13, may otherwise deal with the Company with the same rights it would
          have if it were not Trustee, Paying Agent, Security Registrar or such other agent.

       

      
        22

        
          

      

      

      

      Section 4.6         Money Held in Trust. Money held by the Trustee in trust hereunder need not be segregated from other funds except to the extent required by Law. The Trustee shall be under no liability for interest on any money
          received by it hereunder, except as otherwise agreed by the Trustee in writing with the Company.

      

      

      Section 4.7           Compensation and Reimbursement. The Company agrees:

      

      

      (a)         to pay to the Trustee from time
          to time reasonable compensation for all services rendered by it hereunder in such amount as the Company and the Trustee shall agree from time to time (which compensation shall not be limited by any provision of Law in regard to the compensation
          of a trustee of an express trust);

      

      

      (b)         except as otherwise expressly
          provided herein, to reimburse the Trustee upon its request for all reasonable and out-of-pocket expenses, disbursements and advances incurred or made by the Trustee in accordance with any provision of this CVR Agreement (including the reasonable
          compensation and the reasonable expenses and disbursements of its agents and counsel), except any such expense, disbursement or advance as may be attributable to the Trustee’s negligence, bad faith or willful misconduct; and

      

      

      (c)         to indemnify the Trustee and
          each of its agents, officers, directors and employees (each an “indemnitee”) for, and to hold it harmless against, any loss, liability or reasonable and out-of-pocket
          expense (including reasonable and out-of-pocket attorneys’ fees and expenses) incurred without negligence, bad faith or willful misconduct on its part, arising out of or in connection with the acceptance or administration of this trust and the
          performance of its duties hereunder, including the reasonable and out-of-pocket costs and expenses of defending itself against any claim or liability in connection with the exercise or performance of any of its powers or duties hereunder. The
          Company’s payment obligations pursuant to this Section 4.7 shall survive the termination of this CVR Agreement. When the Trustee incurs reasonable and out-of-pocket
          expenses after the occurrence of an Event of Default specified in Section 8.1(c) or 8.1(d)
          with respect to the Company, the expenses are intended to constitute expenses of administration under bankruptcy Laws.

      

      

      Section 4.8           Disqualification; Conflicting Interests.

      

      

      (a)         If applicable, to the extent
          that the Trustee or the Company determines that the Trustee has a conflicting interest within the meaning of the Trust Indenture Act, the Trustee shall immediately notify the Company of such conflict and, within ninety (90) days after
          ascertaining that it has such conflicting interest, either eliminate such conflicting interest or resign to the extent and in the manner provided by, and subject to the provisions of, the Trust Indenture Act and this CVR Agreement. The Company
          shall take prompt steps to have a successor appointed in the manner provided in this CVR Agreement.

       

      
        23

        
          

      

      

      

      (b)         If the Trustee fails to comply
          with Section 4.8(a), the Trustee shall, within ten (10) days of the expiration of such ninety (90) day period, transmit a notice of such failure to the Holders in the
          manner and to the extent provided in the Trust Indenture Act and this CVR Agreement.

      

      

      (c)         If the Trustee fails to comply
          with Section 4.8(a) after written request therefore by the Company or any Holder, then any Holder of any Security who has been a bona fide Holder for at least six (6)
          months may on behalf of himself and all others similarly situated, petition any court of competent jurisdiction for the removal of such Trustee and the appointment of a successor Trustee.

      

      

      Section 4.9          Corporate Trustee Required; Eligibility. There shall at all times be a Trustee hereunder which satisfies the applicable requirements of Sections 310(a)(1) and (5) of the Trust Indenture Act and has a combined
          capital and surplus of at least one hundred fifty million dollars ($150,000,000). If such corporation publishes reports of condition at least annually, pursuant to Law or to the requirements of a supervising or examining authority, then for the
          purposes of this Section 4.9, the combined capital and surplus of such corporation shall be deemed to be its combined capital and surplus as set forth in its most
          recent report of condition so published. If at any time the Trustee shall cease to be eligible in accordance with the provisions of this Section 4.9, it shall resign
          immediately in the manner and with the effect hereinafter specified in this Article 4.

      

      

      Section 4.10         Resignation and Removal; Appointment of Successor.

      

      

      (a)          No resignation or removal of
          the Trustee and no appointment of a successor Trustee pursuant to this Article 4 shall become effective until the acceptance of appointment by the successor Trustee
          under Section 4.11.

      

      

      (b)          The Trustee, or any trustee or
          trustees hereafter appointed, may resign at any time by giving written notice thereof to the Company. If an instrument of acceptance by a successor Trustee shall not have been delivered to the Trustee within thirty (30) days after the giving of
          such notice of resignation, the resigning Trustee may petition any court of competent jurisdiction for the appointment of a successor Trustee.

      

      

      (c)          The Trustee may be removed at
          any time by an act of the Majority Holders, delivered to the Trustee and to the Company.

      

      

      (d)         If at any time:

      

      

      (i)           the Trustee shall fail to
          comply with Section 4.8 after written request therefor by the Company or by any Holder who has been a bona fide Holder of a Security for at least six (6) months, or

      

      

      (ii)          the Trustee shall cease to be
          eligible under Section 4.9 and shall fail to resign after written request therefor by the Company or by any such Holder, or

       

      
        24

        
          

      

      

      

      (iii)        the Trustee shall become
          incapable of acting or shall be adjudged a bankrupt or insolvent, or a receiver of the Trustee or of its property shall be appointed, or any public officer shall take charge or control of the Trustee or of its property or affairs for the purpose
          of rehabilitation, conservation or liquidation,

      

      

      then, in any case, (A) the Company, by a Board Resolution or an action of the chief executive officer of the Company, may remove the Trustee, or (B) the
          Holder of any Security who has been a bona fide Holder of a Security for at least six (6) months may, on behalf of himself and all others similarly situated, petition any court of competent jurisdiction for the removal of the Trustee and the
          appointment of a successor Trustee.

      

      

      (e)        If the Trustee shall resign, be
          removed or become incapable of acting, or if a vacancy shall occur in the office of Trustee for any cause, the Company, by a Board Resolution or an action of the chief executive officer of the Company, shall promptly appoint a successor Trustee.
          If, within one year after any removal by the Majority Holders, a successor Trustee shall be appointed by act of the Majority Holders delivered to the Company and the retiring Trustee, then the successor Trustee so appointed shall, forthwith upon
          its acceptance of such appointment in accordance with Section 4.11, become the successor Trustee and supersede the successor Trustee appointed by the Company. If no
          successor Trustee shall have been so appointed by the Company or the Majority Holders and accepted appointment within sixty (60) days after the retiring Trustee tenders its resignation or is removed, the retiring Trustee may, or, the Holder of
          any Security who has been a bona fide Holder for at least six (6) months may on behalf of himself and all others similarly situated, petition any court of competent jurisdiction for the appointment of a successor Trustee.

      

      

      (f)         The Company shall give notice of
          each resignation and each removal of the Trustee and each appointment of a successor Trustee by mailing written notice of such event by first-class mail, postage prepaid, to the Holders of Securities as their names and addresses appear in the
          Security Register. Each notice shall include the name of the successor Trustee and the address of its Corporate Trust Office. If the Company fails to send such notice within ten (10) days after acceptance of appointment by a successor Trustee, it
          shall not be a default hereunder but the successor Trustee shall cause the notice to be mailed at the expense of the Company.

      

      

      Section 4.11         Acceptance of Appointment of Successor.

      

      

      (a)         Every successor Trustee
          appointed hereunder shall execute, acknowledge and deliver to the Company and to the retiring Trustee an instrument accepting such appointment, and thereupon the resignation or removal of the retiring Trustee shall become effective and such
          successor Trustee, without any further act, deed or conveyance, shall become vested with all the rights, powers, trusts and duties of the retiring Trustee; but, upon request of the Company or the successor Trustee, such retiring Trustee shall,
          upon payment of its charges, execute and deliver an instrument transferring to such successor Trustee all the rights, powers and trusts of the retiring Trustee, and shall duly assign, transfer and deliver to such successor Trustee all property
          and money held by such retiring Trustee hereunder. Upon request of any such successor Trustee, the Company shall execute any and all instruments for more fully and certainly vesting in and confirming to such successor Trustee all such rights,
          powers and trusts.

       

      
        25

        
          

      

      

      

      (b)          No successor Trustee shall
          accept its appointment unless at the time of such acceptance such successor Trustee shall be qualified and eligible under this Article 4.

      

      

      Section 4.12        Merger, Conversion, Consolidation or Succession to Business. Any corporation into which the Trustee may be merged or converted or with which it may be consolidated, or any corporation resulting from any merger,
          conversion or consolidation to which the Trustee shall be a party, or any corporation succeeding to all or substantially all of the corporate trust business of the Trustee, by sale or otherwise shall be the successor of the Trustee hereunder,
          provided such corporation shall be otherwise qualified and eligible under this Article 4, without the execution or filing of any paper or any further act on the part of
          any of the Parties hereto. In case any Securities shall have been authenticated, but not delivered, by the Trustee then in office, any successor by merger, conversion, sale or consolidation to such authenticating Trustee may adopt such
          authentication and deliver the Securities so authenticated with the same effect as if such successor Trustee had itself authenticated such Securities; and such certificate shall have the full force which it is anywhere in the Securities or in
          this CVR Agreement provided that the certificate of the Trustee shall have; provided that the right to adopt the certificate of authentication of any predecessor
          Trustee shall apply only to its successor or successors by merger, conversion or consolidation.

      

      

      Section 4.13        Preferential Collection of Claims Against Company. If and when the Trustee shall be or shall become a creditor, directly or indirectly, secured or unsecured, of the Company (or any other obligor upon the
          Securities), excluding any creditor relationship set forth in Section 311(b) of the Trust Indenture Act, if applicable, the Trustee shall be subject to the applicable provisions of the Trust Indenture Act regarding the collection of claims
          against the Company (or any such other obligor).

      

      

      ARTICLE 5

      HOLDERS’ LISTS AND REPORTS BY THE TRUSTEE AND COMPANY

      

      

      Section 5.1          Company to Furnish Trustee Names and Addresses of Holders. The Company will furnish or cause to be furnished to the Trustee (a) promptly after the issuance of the Securities, and semi-annually thereafter, a
          list, in such form as the Trustee may reasonably require, of the names and addresses of the Holders as of a recent date, and (b) at such times as the Trustee may request in writing, within thirty (30) days after receipt by the Company of any such
          request, a list, in such form as the Trustee may reasonably require, of the names and addresses of the Holders as of a date not more than fifteen (15) days prior to the time such list is furnished; provided, however, that if and so long as the Trustee shall be the Security Registrar, no such list need be furnished.

      

      

      Section 5.2           Preservation of Information; Communications to Holders.

      

      

      (a)         The Trustee shall preserve, in
          as current a form as is reasonably practicable, the names and addresses of the Holders contained in the most recent list furnished to the Trustee as provided in Section 5.1
          and the names and addresses of Holders received by the Trustee in its capacity as Security Registrar. The Trustee may destroy any list furnished to it as provided in Section 5.1 upon receipt of a new list so furnished.

       

      
        26

        
          

      

      

      

      (b)         The rights of the Holders to
          communicate with other Holders with respect to their rights under this CVR Agreement and the corresponding rights and privileges of the Trustee shall be as provided by Section 312(b)(2) of the Trust Indenture Act, if applicable.

      

      

      (c)         Every Holder of Securities, by
          receiving and holding the same, agrees with the Company and the Trustee that neither the Company nor the Trustee shall be deemed to be in violation of Law or held accountable by reason of the disclosure of any such information as to the names and
          addresses of the Holders made pursuant to the Trust Indenture Act (if applicable) regardless of the source from which such information was derived.

      

      

      Section 5.3           Reports by Trustee.

      

      

      (a)         Within sixty (60) days after
          December 31 of each year commencing with the December 31 following the date of this CVR Agreement, the Trustee shall transmit to all Holders such reports concerning the Trustee and its actions under this CVR Agreement as may be required pursuant
          to the Trust Indenture Act to the extent and in the manner provided pursuant thereto. The Trustee shall also comply with Section 313(b)(2) of the Trust Indenture Act, if applicable. The Trustee shall also transmit by mail all reports as required
          by Section 313(c) of the Trust Indenture Act, if applicable.

      

      

      (b)         A copy of each such report
          shall, at the time of such transmission to the Holders, be filed by the Trustee with each stock exchange, if any, upon which the Securities are listed, with the Commission and also with the Company. The Company will promptly notify the Trustee
          when the Securities are listed on any stock exchange.

      

      

      Section 5.4           Reports by Company.

      

      

      (a)          The Company shall file with the
          Trustee, within fifteen (15) days after the Company files or furnishes the same with the Commission, copies of an annual report filed on Form 10-K or a quarterly reports filed on Form 10-Q and of the information, documents and other reports (or
          copies of such portions of any of the foregoing as the Commission may from time to time by rules and regulations prescribe) which the Company is required to file with the Commission pursuant to Section 13 or Section 15(d) of the Exchange Act
          (such annual and quarterly reports and required information, documents and other reports, together the “Exchange Act Documents”).

      

      

      (b)         Delivery of the reports,
          information and documents described in Section 5.4(a) shall not constitute constructive notice of any information contained therein or determinable there from,
          including the Company’s compliance with any of its covenants or other obligations hereunder as to which the Trustee is entitled to rely exclusively on Officer’s Certificates.

       

      
        27

        
          

      

      

      

      ARTICLE 6

      AMENDMENTS

      

      

      Section 6.1          Amendments Without Consent of Holders. Without the consent of any Holders, the Company and the Trustee, at any time and from time to time, may enter into one or more amendments hereto or to the Securities, for
          any of the following purposes:

      

      

      (a)          to convey, transfer, assign,
          mortgage or pledge to the Trustee as security for the Securities any property or assets;

      

      

      (b)         to evidence the succession of
          another Person to the Company, and the assumption by any such successor of the covenants of the Company herein and in the Securities;

      

      

      (c)          to add to the covenants of the
          Company such further covenants, restrictions, conditions or provisions as the Company and the Trustee shall consider to be for the protection of the Holders of Securities, and to make the occurrence, or the occurrence and continuance, of a
          default in any such additional covenants, restrictions, conditions or provisions an Event of Default permitting the enforcement of all or any of the several remedies provided in this CVR Agreement as herein set forth; provided, that in respect of any such additional covenant, restriction, condition or provision, such amendment may provide for a particular period of grace after default (which period may be
          shorter or longer than that allowed in the case of other defaults) or may provide for an immediate enforcement upon such an Event of Default or may limit the remedies available to the Trustee upon such an Event of Default or may limit the right
          of the Majority Holders to waive such an Event of Default;

      

      

      (d)        to cure any ambiguity, or to
          correct or supplement any provision herein or in the Securities which may be defective or inconsistent with any other provision herein; provided, that such provisions shall not materially reduce the benefits of this CVR Agreement or the
          Securities to the Holders;

      

      

      (e)          to make any other provisions
          with respect to matters or questions arising under this CVR Agreement; provided, that such provisions shall not adversely affect the interests of the Holders;

      

      

      (f)          to make any amendments or
          changes necessary to comply or maintain compliance with the Trust Indenture Act, if applicable; or

      

      

      (g)         make any other change that does
          not adversely affect the interests of the Holders.

      

      

      Promptly following any amendment of this CVR Agreement or the Securities in accordance with this Section 6.1, the Trustee shall notify the Holders of the Securities of such amendment; provided that any failure so to notify the Holders shall
          not affect the validity of such amendment.

      

      

      Section 6.2         Amendments with Consent of Holders. With the consent of the Majority Holders, by Act of said Holders delivered to the Company and the Trustee, the Company (when authorized by a Board Resolution or the chief
          executive officer of the Company) and the Trustee may enter into one or more amendments hereto or to the Securities for the purpose of adding any provisions to or changing in any manner or eliminating any of the provisions of this CVR Agreement
          or to the Securities or of modifying in any manner the rights of the Holders under this CVR Agreement or to the Securities; provided, however, that no such amendment shall, without the consent of the Holder of each Outstanding Security affected thereby:

       

      
        28

        
          

      

      

      

      (a)         modify in a manner adverse to
          the Holders (i) any provision contained herein with respect to the termination of this CVR Agreement or the Securities, (ii) the time for payment and amount of the Milestone Payment, or otherwise extend the time for payment of the Securities or
          reduce the amounts payable in respect of the Securities or modify any other payment term or payment date;

      

      

      (b)         reduce the number of CVRs, the
          consent of whose Holders is required for any such amendment; or

      

      

      (c)         modify any of the provisions of
          this Section 6.2, except to increase the percentage of Holders from whom consent or approval is required or to provide that certain other provisions of this CVR
          Agreement cannot be modified or waived without the consent of the Holder of each Security affected thereby.

      

      

      It shall not be necessary for any Act of Holders under this Section
              6.2 to approve the particular form of any proposed amendment, but it shall be sufficient if such Act shall approve the substance thereof.

      

      

      Section 6.3          Execution of Amendments. In executing any amendment permitted by this Article 6, the Trustee (subject to Section 4.1) shall be fully protected in relying upon an Opinion of Counsel stating that the execution of such amendment is authorized or permitted by this CVR Agreement. The Trustee shall
          execute any amendment authorized pursuant to this Article 6 if the amendment does not adversely affect the Trustee’s own rights, duties or immunities under this CVR
          Agreement or otherwise. Otherwise, the Trustee may, but need not, execute such amendment.

      

      

      Section 6.4          Effect of Amendments; Notice to Holders.

      

      

      (a)         Upon the execution of any
          amendment under this Article, this CVR Agreement and the Securities shall be modified in accordance therewith, and such amendment shall form a part of this CVR Agreement and the Securities for all purposes; and every Holder of Securities
          theretofore or thereafter authenticated, as applicable, and delivered hereunder shall be bound thereby.

      

      

      (b)         Promptly after the execution by
          the Company and the Trustee of any amendment pursuant to the provisions of this Article 6, the Company shall mail a notice thereof by first class mail to the Holders of
          Securities at their addresses as they shall appear on the Security Register, setting forth in general terms the substance of such amendment. Any failure of the Company to mail such notice, or any defect therein, shall not, however, in any way
          impair or affect the validity of any such amendment.

       

      
        29

        
          

      

      

      

      Section 6.5          Conformity with Trust Indenture Act. Every amendment executed pursuant to this Article 6 shall conform to the applicable
          requirements of the Trust Indenture Act, if any.

      

      

      Section 6.6         Reference in Securities to Amendments. If an amendment changes the terms of a Security, the Trustee may require the Holder of the Security to deliver it to the Trustee. Global Securities authenticated and
          delivered after the execution of any amendment pursuant to this Article 6 may, and shall if required by the Trustee, bear a notation in form approved by the Trustee as
          to any matter provided for in such amendment. If the Company shall so determine, new Securities so modified as to conform, in the opinion of the Trustee, on the on hand, and the Board of Directors or the chief executive officer of the Company, on
          the other hand, to any such amendment may be prepared and executed by the Company, as applicable, and authenticated, as applicable, and delivered by the Trustee in exchange for Outstanding Securities. Failure to make the appropriate notation or
          to issue a new Security shall not affect the validity of such amendment.

      

      

      ARTICLE 7

      COVENANTS

      

      

      Section 7.1         Payment of Amounts, if any, to Holders. The Company will duly and punctually pay the amounts, if any, on the Securities in
          accordance with the terms of this CVR Agreement. Such amounts shall be considered paid on the Milestone Payment Date if on or prior to such date the Company makes, or causes to be made, the payment required pursuant to Section 3.1(c) of this CVR Agreement. Notwithstanding any other provision of this CVR Agreement, the Company or any of its Affiliates, the Trustee or the Paying Agent, shall be entitled to deduct and withhold, or cause to be deducted and withheld, from any amounts payable or otherwise deliverable pursuant to this CVR Agreement to any Person, such amounts as are
            required to be deducted and withheld therefrom under the Code, or any provision of state, local or foreign Tax Law. To the extent that amounts are so deducted and withheld
            by the Company or any of its Affiliates, the Trustee or the Paying Agent, such withheld amounts shall be (a) paid over to the applicable Governmental Entity in accordance with applicable Law and (b) treated for all purposes of this CVR
            Agreement as having been paid to the Person in respect of which such deduction and withholding was made by the Company or any of its Affiliates, the Trustee or the Paying Agent, as the case may be. The consent of Holder shall not be required
            for any such withholding.

      

      

      Section 7.2           Maintenance of Office or Agency.

      

      

      (a)         As long as any of the Securities
          remain Outstanding, the Company will maintain in the Borough of Manhattan, The City of New York, an office or agency (i) where Securities may be presented or surrendered for payment, (ii) where Securities may be surrendered for registration of
          transfer or exchange and (iii) where notices and demands to or upon the Company in respect of the Securities and this CVR Agreement may be served. The office or agency of the Trustee at [Address], New York, New York [Zip Code] shall be such
          office or agency of the Company, unless the Company shall designate and maintain some other office or agency for one or more of such purposes. The Company or any of its Subsidiaries may act as Paying Agent, registrar or transfer agent; provided
          that such Person shall take appropriate actions to avoid the commingling of funds. The Company will give prompt written notice to the Trustee of any change in the location of any such office or agency. If at any time the Company shall fail to
          furnish the Trustee with the address thereof, such presentations, surrenders, notices and demands may be made or served at the Corporate Trust Office of the Trustee, and the Company hereby appoints the Trustee as its agent to receive all such
          presentations, surrenders, notices and demands.

       

      
        30

        
          

      

      

      

      (b)          The Company may from time to
          time designate one or more other offices or agencies (in or outside of The City of New York) where the Securities may be presented or surrendered for any or all such purposes, and may from time to time rescind such designation; provided, however,
          that no such designation or rescission shall in any manner relieve the Company of its obligation to maintain an office or agency in the Borough of Manhattan, The City of New York for such purposes. The Company will give prompt written notice to
          the Trustee of any such designation or rescission and any change in the location of any such office or agency.

      

      

      Section 7.3           Money for Security Payments to Be Held in Trust.

      

      

      (a)          If the Company or any of its
          Subsidiaries shall at any time act as the Paying Agent, it will, on or before the Milestone Payment Date segregate and hold in trust for the benefit of the Holders all sums held by such Paying Agent for payment on the Securities until such sums shall be paid to the Holders as herein provided, and will promptly notify the Trustee of any default by the Company in making payment on the Securities.

      

      

      (b)        Whenever the Company shall have
          one or more Paying Agents for the Securities, it will, on or before the Milestone Payment Date deposit with a Paying Agent a sum in same day funds sufficient to pay the amount, if any, so becoming due; such sum to be held in trust for the benefit
          of the Persons entitled to such amount, and (unless such Paying Agent is the Trustee) the Company will promptly notify the Trustee of such action or any failure so to act.

      

      

      (c)         The Company will cause each
          Paying Agent other than the Trustee to execute and deliver to the Trustee an instrument in which such Paying Agent shall agree with the Trustee, subject to the provisions of this Section

              7.3, that (i) such Paying Agent will hold all sums held by it for the payment of any amount payable on Securities in trust for the benefit of the Persons entitled thereto until such sums shall be paid to such Persons or otherwise
          disposed of as herein provided and will notify the Trustee of the sums so held and (ii) that it will give the Trustee notice of any failure by the Company (or by any other obligor on the Securities) to make any payment on the Securities when the
          same shall be due and payable.

      

      

      (d)        Any money deposited with the
          Trustee or any Paying Agent, or then held by the Company, in trust for the payment on any Security and remaining unclaimed for one year after the Milestone Payment Date shall be paid to the Company on Company Request, or (if then held by the
          Company) shall be discharged from such trust; and the Holder of such Security shall thereafter, as an unsecured general creditor, look only to the Company for payment thereof, and all liability of the Trustee or such Paying Agent with respect to
          such trust money shall thereupon cease.

       

      
        31

        
          

      

      

      

      Section 7.4         Certain Purchases and Sales. Nothing contained herein shall prohibit the Company or any of its Subsidiaries or Affiliates from acquiring in open market transactions, private transactions or otherwise, any
          Securities.

      

      

      Section 7.5        Books and Records. During the term of this Agreement and for a period of three (3) years after the Termination Date, the Company shall use commercially reasonable efforts to keep, and shall cause its
          Subsidiaries to use commercially reasonable efforts to keep, true, complete and accurate records in reasonably sufficient detail to enable the Holders to determine if the Company has complied with its obligations under this CVR Agreement.

      

      

      Section 7.6         Listing of CVRs. The Company hereby covenants and agrees to use reasonable best efforts to cause the Securities to be approved for listing (subject to notice of issuance) for trading on the New York Stock
          Exchange or other national securities exchange and will use its reasonable best efforts to maintain such listing for so long as any CVRs remain Outstanding.

      

      

      Section 7.7          Product Transfer. If the Company or its Affiliates, directly or indirectly, by a sale or swap of assets, merger, reorganization, joint venture, lease, license or any other transaction or arrangement, sells,
          transfers, conveys or otherwise disposes of its respective rights in and to any Product to a third party (other than the Company or any of its Subsidiaries), then the applicable Milestone for such Product (e.g., if the Product is BB2121, then the
          BB2121 Milestone) shall be deemed to have been satisfied for all purposes under this CVR Agreement as of the earlier of the entry into a definitive agreement with respect to, and the consummation of, the transaction or arrangement involving such
          sale, transfer, conveyance or other disposition; provided, that if such sale, transfer, conveyance or other disposition is permitted by Section 9.1, then Section 9.1 shall govern. For the purposes of clarification, and subject to Section 7.8, the Company may use contract research organizations, contract manufacturing organizations, contract sales organizations, subcontractors and distributors in the ordinary course of
          business to perform research, development, manufacturing and commercialization activities (including granting an appropriate sublicense to the extent necessary), without triggering the applicable Milestone.

      

      

      Section 7.8           Diligent Efforts. The Company shall use Diligent Efforts to achieve the Milestone.

       

      
        32

        
          

      

      

      

      Section 7.9          Confidentiality. The Trustee and the Holders hereby agree that any confidential or non-public information they receive from or on behalf of the Company or any Affiliate of the Company, which receipt arises out
          of the transactions contemplated by this CVR Agreement (the “Confidential Information”), shall: (a) not be used for any purpose other than for purposes permitted under
          this CVR Agreement; (b) not be used directly or indirectly in any way that is for competitive purposes; and (c) not be disclosed by, and be kept confidential by, such Trustee and the Holders and its directors, officers, members, managers,
          employees, affiliates and agents (collectively, “Representatives”); provided, however, that any such Confidential Information may be disclosed only to their Representatives who (i) need to know such Confidential Information and (ii) are bound in
          writing to a non-disclosure agreement no less restrictive than this Section 7.9. It is understood that such Representatives shall be informed by the Trustee or the
          applicable Holder of the confidential nature of such Confidential Information, and that the Trustee or such Holder, as applicable, shall be responsible for any disclosure or use made by its Representatives in breach of obligations under this CVR
          Agreement to the same extent as if such disclosure or use had been made directly by the Trustee or such Holder, as applicable. Each of the Trustee and the Holders will as soon as practicable notify the Company of any breach of this CVR Agreement
          of which they become aware, and will use commercially reasonable efforts to assist and cooperate with the Company in minimizing the consequences of such breach. “Confidential Information” shall not include any information that is (A) publicly
          available other than because of or related to any disclosure by the Trustee or the Holders or any of their respective Representatives or (B) is lawfully disclosed to the Trustee or Holders by sources (other than the Company or its Affiliates)
          rightfully in possession of the Confidential Information on a non-confidential basis. If the Trustee, Holders or their respective Representatives are legally required or requested to disclose any Confidential Information, they will in advance of
          such disclosure, unless otherwise prohibited by Law, promptly notify the Company in writing of such request or requirement so that the Company may seek to avoid or minimize the required disclosure and/or obtain an appropriate protective order or
          other appropriate relief to ensure that any Confidential Information so disclosed is maintained in confidence to the maximum extent possible by the person receiving the disclosure, or, in the Company’s discretion, to waive compliance with the
          provisions of this CVR Agreement. In any such case, the Trustee and the Holders agree to cooperate and use reasonable efforts to avoid or minimize the required disclosure and/or
            obtain such protective order or other relief. If, in the absence of a protective order or the receipt of a waiver hereunder, the Trustee, Holders or their respective Representatives are legally obligated to disclose any Confidential
            Information, they will disclose only so much thereof to the party compelling disclosure as they believe in good faith, on the basis of advice of counsel, is required by Law. The Trustee and Holders shall give the Company prior written notice of
            the specific Confidential Information that they believe they are required to disclose under such circumstances. All Confidential Information disclosed by or on behalf of the Company or any of its Affiliates shall be, and shall remain, the
            property of the Company or such Affiliate.

      

      

      Section 7.10       Non-Use of Name. Neither the Trustee nor the Holders shall use the name, trademark, trade name, or logo of the Company, its Affiliates or their respective employees, agents or representatives in any publicity
          or news release relating to this CVR Agreement or its subject matter, without the prior express written permission of the Company.

      

      

      Section 7.11         Notice of Default. The Company shall file with the Trustee written notice of the occurrence of any Event of Default or other default under this CVR Agreement within five (5) Business Days of its becoming aware
          of such Event of Default or other default.

       

      
        33

        
          

      

      

      

      ARTICLE 8

      REMEDIES OF THE TRUSTEE AND HOLDERS

      ON EVENT OF DEFAULT

      

      

      Section 8.1          Event of Default Defined; Waiver of Default. “Event of Default” with respect to the Securities, means each one of the following
          events which shall have occurred and be continuing (whatever the reason for such Event of Default and whether it shall be voluntary or involuntary or be effected by operation of Law or pursuant to any judgment, decree or order of any court or any
          order, rule or regulation of any administrative or governmental body):

      

      

      (a)          default in the payment by the
          Company pursuant to the terms of this CVR Agreement of all or any part of the Milestone Payment after a period of ten (10) Business Days after the Milestone Payment shall become due and payable on the Milestone Payment Date; or

      

      

      (b)        material default in the
          performance, or breach in any material respect, of any covenant or warranty of the Company in respect of the Securities (other than a covenant or warranty in respect of the Securities, a default in whose performance or whose breach is elsewhere
          in this Section 8.1 specifically dealt with), and continuance of such default or breach for a period of ninety (90) days after there has been given, by registered or
          certified mail, to the Company by the Trustee or to the Company and the Trustee by the Majority Holders, a written notice specifying such default or breach and requiring it to be remedied and stating that such notice is a “Notice of Default”
          hereunder; or

      

      

      (c)         a court having jurisdiction in
          the premises shall enter a decree or order for relief in respect of the Company in an involuntary case under any applicable bankruptcy, insolvency or other similar Law now or hereafter in effect, or appointing a receiver, liquidator, assignee,
          custodian, trustee or sequestrator (or similar official) of the Company or for any substantial part of its property or ordering the winding up or liquidation of its affairs, and such decree or order shall remain unstayed and in effect for a
          period of ninety (90) consecutive days; or

      

      

      (d)         the Company shall commence a
          voluntary case under any applicable bankruptcy, insolvency or other similar Law now or hereafter in effect, or consent to the entry of an order for relief in an involuntary case under any such Law, or consent to the appointment of or taking
          possession by a receiver, liquidator, assignee, custodian, trustee or sequestrator (or similar official) of the Company or for any substantial part of its property, or make any general assignment for the benefit of creditors.

      

      

      If an Event of Default described above occurs and is continuing, then, and in each and every such case, either the Trustee by notice
          in writing to the Company or the Trustee upon the written request of the Majority Holders by notice in writing to the Company (and to the Trustee if given by the Majority Holders), shall bring suit to protect the rights of the Holders, including
          to obtain payment for any amounts then due and payable, which amounts shall bear interest at the Default Interest Rate from the date such amounts were due and payable hereunder until payment is made to the Trustee.

       

      
        34

        
          

      

      

      

      The foregoing provisions of this Section 8.1, however,
          are subject to the condition that if, at any time after the Trustee shall have begun such suit, and before any judgment or decree for the payment of the moneys due shall have been obtained or entered as hereinafter provided, the Company shall pay
          or shall deposit with the Trustee a sum sufficient to pay all amounts which shall have become due (with interest upon such overdue amount at the Default Interest Rate to the date of such payment or deposit) and such amount as shall be sufficient
          to cover reasonable compensation to the Trustee, its agents, attorneys and counsel, and all other expenses and liabilities incurred and all advances made, by the Trustee, and if any and all Events of Default under this CVR Agreement shall have
          been cured, waived or otherwise remedied as provided herein, then and in every such case the Majority Holders, by written notice to the Company and to the Trustee, may waive all defaults with respect to the Securities, but no such waiver or
          rescission and annulment shall extend to or shall affect any subsequent default or shall impair any right consequent thereof.

      

      

      Section 8.2         Collection by the Trustee; the Trustee May Prove Payment Obligations. The Company covenants that in case default shall be made in the payment of all or any part of the Securities when the same shall have become
          due and payable, whether at the Milestone Payment Date or otherwise, then upon demand of the Trustee, the Company will pay to the Trustee for the benefit of the Holders of the Securities the whole amount that then shall have become due and
          payable on all Securities (with interest from the date due and payable to the date of such payment upon the overdue amount at the Default Interest Rate); and in addition thereto, such further amount as shall be sufficient to cover the costs and
          expenses of collection, including reasonable compensation to the Trustee and each predecessor Trustee, their respective agents, attorneys and counsel, and any expenses and liabilities incurred, and all advances made, by the Trustee and each
          predecessor Trustee, except as a result of its negligence, bad faith or willful misconduct.

      

      

      The Trustee may in its discretion proceed to protect and enforce its rights and the rights of the Holders by such appropriate judicial
          proceedings as the Trustee shall deem most effectual to protect and enforce any such rights, whether for the specific enforcement of any covenant or agreement in this CVR Agreement or in aid of the exercise of any power granted herein, or to
          enforce any other remedy.

      

      

      In case the Company shall fail forthwith to pay such amounts upon such demand, the Trustee, in its own name and as trustee of an
          express trust, shall be entitled and empowered to institute any action or proceedings at Law or in equity for the collection of the sums so due and unpaid, and may prosecute any such action or proceedings to judgment or final decree, and may
          enforce any such judgment or final decree against the Company or other obligor upon such Securities and collect in the manner provided by Law out of the property of the Company or other obligor upon such Securities, wherever situated, the moneys
          adjudged or decreed to be payable.

       

      
        35

        
          

      

      

      

      In any judicial proceedings relative to the Company or other obligor upon the Securities, irrespective of whether any amount is then
          due and payable with respect to the Securities, the Trustee is authorized:

      

      

      (a)        to file and prove a claim or
          claims for the whole amount owing and unpaid in respect of the Securities, and to file such other papers or documents as may be necessary or advisable in order to have the claims of the Trustee (including any claim for reasonable compensation to
          the Trustee and each predecessor Trustee, and their respective agents, attorneys and counsel, and for reimbursement of all expenses and liabilities incurred, and all advances made, by the Trustee and each predecessor Trustee, except as a result
          of negligence, bad faith or willful misconduct) and of the Holders allowed in any judicial proceedings relative to the Company or other obligor upon the Securities, or to their respective property;

      

      

      (b)         unless prohibited by and only to
          the extent required by applicable Law, to vote on behalf of the Holders in any election of a trustee or a standby trustee in arrangement, reorganization, liquidation or other bankruptcy or insolvency proceedings or person performing similar
          functions in comparable proceedings; and

      

      

      (c)         to collect and receive any
          moneys or other property payable or deliverable on any such claims, and to distribute all amounts received with respect to the claims of the Holders and of the Trustee on their behalf; and any trustee, receiver, or liquidator, custodian or other
          similar official is hereby authorized by each of the Holders to make payments to the Trustee, and, in the event that the Trustee shall consent to the making of payments directly to the Holders, to pay to the Trustee such amounts as shall be
          sufficient to cover reasonable compensation to the Trustee, each predecessor Trustee and their respective agents, attorneys and counsel, and all other expenses and liabilities incurred, and all advances made, by the Trustee and each predecessor
          Trustee, except as a result of its negligence, bad faith or willful misconduct, and all other amounts due to the Trustee or any predecessor Trustee pursuant to Section 4.6.
          To the extent that such payment of reasonable compensation, expenses, disbursements, advances and other amounts out of the estate in any such proceedings shall be denied for any reason, payment of the same shall be secured by a lien on, and shall
          be paid out of, any and all distributions, dividends, moneys, securities and other property which the Holders may be entitled to receive in such proceedings, whether in liquidation or under any plan of reorganization or arrangement or otherwise.

      

      

      Nothing herein contained shall be deemed to authorize the Trustee to authorize or consent to or vote for or accept or adopt on behalf
          of any Holder any plan of reorganization, arrangement, adjustment or composition affecting the Securities, or the rights of any Holder thereof, or to authorize the Trustee to vote in respect of the claim of any Holder in any such proceeding
          except, as aforesaid, to vote for the election of a trustee in bankruptcy or similar person.

      

      

      All rights of action and of asserting claims under this CVR Agreement, or under any of the Securities, may be enforced by the Trustee
          without the possession of any of the Securities or the production thereof and any trial or other proceedings instituted by the Trustee shall be brought in its own name as trustee of an express trust, and any recovery of judgment, subject to the
          payment of the expenses, disbursements and compensation of the Trustee, each predecessor Trustee and their respective agents and attorneys, shall be for the ratable benefit of the Holders.

       

      
        36

        
          

      

      

      

      In any proceedings brought by the Trustee (and also any proceedings involving the interpretation of any provision of this CVR
          Agreement to which the Trustee shall be a party) the Trustee shall be held to represent all the Holders, and it shall not be necessary to make any Holders of such Securities parties to any such proceedings.

      

      

      Section 8.3          Application of Proceeds. Any monies collected by the Trustee pursuant to this Article 8 in respect of any Securities shall be
          applied in the following order at the date or dates fixed by the Trustee upon presentation of the several Securities in respect of which monies have been collected and stamping (or otherwise noting) thereon the payment in exchange for the
          presented Securities if only partially paid or upon surrender thereof if fully paid:

      

      

      FIRST: To the payment of costs and expenses in respect of which monies have been collected, including reasonable compensation to the
          Trustee and each predecessor Trustee and their respective agents and attorneys and of all expenses and liabilities incurred, and all advances made, by the Trustee and each predecessor Trustee, except as a result of its negligence, bad faith or
          willful misconduct, and all other amounts due to the Trustee or any predecessor Trustee pursuant to Section 4.7;

      

      

      SECOND: To the payment of the whole amount then owing and unpaid upon all the Securities, with interest at the Default Interest Rate
          on all such amounts, and in case such monies shall be insufficient to pay in full the whole amount so due and unpaid upon the Securities, then to the payment of such amounts without preference or priority of any security over any other Security,
          ratably to the aggregate of such amounts due and payable; and

      

      

      THIRD: To the payment of the remainder, if any, to the Company or any other person lawfully entitled thereto.

      

      

      Section 8.4         Suits for Enforcement. In case an Event of Default has occurred, has not been waived and is continuing, the Trustee may in its discretion proceed to protect and enforce the rights vested in it by this CVR
          Agreement by such appropriate judicial proceedings as the Trustee shall deem most effectual to protect and enforce any of such rights, either at Law or in equity or in bankruptcy or otherwise, whether for the specific enforcement of any covenant
          or agreement contained in this CVR Agreement or in aid of the exercise of any power granted in this CVR Agreement or to enforce any other legal or equitable right vested in the
            Trustee by this CVR Agreement or by Law.

      

      

      Section 8.5           Restoration of Rights on Abandonment of Proceedings. In case the Trustee or any Holder shall have proceeded to enforce any right under this CVR Agreement and such proceedings shall have been discontinued or
          abandoned for any reason, or shall have been determined adversely to the Trustee or to such Holder, then and in every such case the Company and the Trustee and the Holders shall be restored respectively to their former positions and rights
          hereunder, and all rights, remedies and powers of the Company, the Trustee and the Holders shall continue as though no such proceedings had been taken.

       

      
        37

        
          

      

      

      

      Section 8.6         Limitations on Suits by Holders. Subject to the rights of the holders under Section 8.7, no Holder of any Security shall have any
          right by virtue or by availing of any provision of this CVR Agreement to institute any action or proceeding at Law or in equity or in bankruptcy or otherwise upon or under or with respect to this CVR Agreement, or for the appointment of a
          trustee, receiver, liquidator, custodian or other similar official or for any other remedy hereunder, unless such Holder previously shall have given to the Trustee written notice of default and of the continuance thereof, as hereinbefore
          provided, and unless also the Majority Holders shall have made written request upon the Trustee to institute such action or proceedings in its own name as trustee hereunder and shall have offered to the Trustee such reasonable indemnity as it may
          require against the costs, expenses and liabilities to be incurred therein or thereby and the Trustee for fifteen (15) days after its receipt of such notice, request and offer of indemnity shall have failed to institute any such action or
          proceeding and no direction inconsistent with such written request shall have been given to the Trustee pursuant to Section 8.9. For the protection and enforcement of
          the provisions of this Section 8.6, each and every Holder and the Trustee shall be entitled to such relief as can be given either at Law or in equity.

      

      

      Section 8.7           Unconditional Right of Holders to Institute Certain Suits. Notwithstanding any other provision in this CVR Agreement and any provision of any Security, the right of any Holder of any Security to receive payment
          of the amounts payable in respect of such Security on or after the respective due dates expressed in such Security, or to institute suit for the enforcement of any such payment on or after such respective dates, shall not be impaired or affected
          without the consent of such Holder.

      

      

      Section 8.8           Powers and Remedies Cumulative; Delay or Omission Not Waiver of Default.

      

      

      (a)         Except as provided in Section 8.6, no right or remedy herein conferred upon or reserved to the Trustee or to the Holders is intended to be exclusive of any other right or remedy, and every right
          and remedy shall, to the extent permitted by Law, be cumulative and in addition to every other right and remedy given hereunder or now or hereafter existing at Law or in equity or otherwise. The assertion or employment of any right or remedy
          hereunder, or otherwise, shall not prevent the concurrent assertion or employment of any other appropriate right or remedy.

      

      

      (b)         No delay or omission of the
          Trustee or of any Holder to exercise any right or power accruing upon any Event of Default occurring and continuing as aforesaid shall impair any such right or power or shall be
            construed to be a waiver of any such Event of Default or an acquiescence therein; and, subject to Section 8.6, every power and remedy given by this CVR Agreement or by Law to the Trustee or to the Holders may be exercised from time to time, and as often as shall be deemed expedient, by the Trustee or by the Holders.

       

      
        38

        
          

      

      

      

      Section 8.9           Control by Holders.

      

      

      (a)          The Majority Holders shall have
          the right to direct the time, method and place of conducting any proceeding for any remedy available to the Trustee, or exercising any power conferred on the Trustee with respect to the Securities by this CVR Agreement; provided that such direction shall not be otherwise than in accordance with Law and the provisions of this CVR Agreement; and provided further that (subject to the provisions of Section 4.1) the Trustee shall have the right to
          decline to follow any such direction if the Trustee, being advised by counsel, shall determine that the action or proceeding so directed may not lawfully be taken or if the Trustee in good faith by its board of directors, the executive committee,
          or a committee of directors or Responsible Officers of the Trustee shall determine that the action or proceedings so directed would involve the Trustee in personal liability or if the Trustee in good faith shall so determine that the actions or
          forbearances specified in or pursuant to such direction would be unduly prejudicial to the interests of Holders of the Securities not joining in the giving of said direction.

      

      

      (b)         Nothing in this CVR Agreement
          shall impair the right of the Trustee in its discretion to take any action deemed proper by the Trustee and which is not inconsistent with such direction or directions by Holders.

      

      

      Section 8.10        Waiver of Past Defaults.

      

      

      (a)         In the case of a default or an
          Event of Default specified in clause (b), (c) or (d) of Section 8.1, the Majority Holders may waive any such default or Event of Default, and its consequences except a
          default in respect of a covenant or provisions hereof which cannot be modified or amended without the consent of the Holder of each Security affected. In the case of any such waiver, the Company, the Trustee and the Holders of the Securities
          shall be restored to their former positions and rights hereunder, respectively; but no such waiver shall extend to any subsequent or other default or impair any right consequent thereon.

      

      

      (b)         Upon any such waiver, such
          default shall cease to exist and be deemed to have been cured and not to have occurred, and any Event of Default arising therefrom shall be deemed to have been cured, and not to have occurred for every purpose of this CVR Agreement; but no such
          waiver shall extend to any subsequent or other default or Event of Default or impair any right consequent thereon.

      

      

      Section 8.11        The Trustee to Give Notice of Default, But May Withhold in Certain Circumstances. The Trustee shall transmit to the Holders, as the names and addresses of such Holders appear on the Security Register (as
          provided under Section 313(c) of the Trust Indenture Act, if applicable), notice by mail of all defaults which have occurred and are known to the Trustee, such notice to be transmitted within ninety (90) days after the occurrence thereof, unless
          such defaults shall have been cured before the giving of such notice (the term “default” for the purposes of this Section being hereby defined to mean any event or condition which
            is, or with notice or lapse of time or both would become, an Event of Default); provided that, except in the case of default in the payment of the amounts payable in respect of any of the Securities, the Trustee shall be protected in
            withholding such notice if and so long as the board of directors, the executive committee, or a trust committee of directors or trustees and/or Responsible Officers of the Trustee in good faith determines that the withholding of such notice is
            in the interests of the Holders.

       

      
        39

        
          

      

      

      

      Section 8.12       Right of Court to Require Filing of Undertaking to Pay Costs. All Parties to this CVR Agreement agree, and each Holder of any Security by his acceptance thereof shall be deemed to have agreed, that any court
          may in its discretion require, in any suit for the enforcement of any right or remedy under this CVR Agreement or in any suit against the Trustee for any action taken, suffered or omitted by it as the Trustee, the filing by any party litigant in
          such suit of an undertaking to pay the reasonable out-of-pocket costs of such suit, and that such court may in its discretion assess reasonable out-of-pocket costs, including reasonable out-of-pocket attorneys’ fees, against any party litigant in
          such suit, having due regard to the merits and good faith of the claims or defenses made by such party litigant; but the provisions of this Section 8.12 shall not apply
          to any suit instituted by the Trustee, to any suit instituted by any Holder or group of Holders holding in the aggregate more than ten percent (10%) of the Securities Outstanding or to any suit instituted by any Holder for the enforcement of the
          payment of any Security on or after the due date expressed in such Security.

      

      

      ARTICLE 9

      CONSOLIDATION, MERGER, SALE OR CONVEYANCE

      

      

      Section 9.1           Company May Consolidate, etc., on Certain Terms. The
          Company covenants that it will not merge or consolidate with or into any other Person or sell or convey all or substantially all of its assets to any Person, unless (a) either (i) the Company shall be the continuing Person or (ii) the successor
          Person, or the Person that acquires by sale or conveyance substantially all the assets of the Company shall be a Person organized under the Laws of the United States of America or any State thereof, any member of the European Union or the United
          Kingdom and shall expressly assume, by an assignment and assumption agreement, executed and delivered to the Trustee, in substantially the form attached hereto as Annex B,
          the due and punctual payment of the Milestone Payment and the due and punctual performance and observance of all covenants and conditions of this CVR Agreement to be performed or observed by the Company and (b) the Company, such successor Person
          or Person that acquires by sale or conveyance substantially all the assets of the Company, as the case may be, shall not, immediately after such merger or consolidation, or such sale or conveyance, be in default in the performance of any such
          covenant or condition in any material respect.

      

      

      Section 9.2           Successor Person Substituted.

      

      

      (a)         In case of an assumption
          pursuant to Section 9.1(a)(ii), such assuming Person shall succeed to and be substituted for the Company with the same effect as if it had been named herein. Such
          assuming Person may cause to be signed, and may issue either in its own name (or, if it is the successor to the Company or substantially all assets of the Company, in the name of the Company prior to such succession) any or all of the Securities
          issuable hereunder, in the case of Global Securities, which theretofore shall not have been signed by the Company and delivered to the Trustee; and, upon the order of such successor corporation instead of the Company and subject to all the terms,
          conditions and limitations in this CVR Agreement prescribed, the Trustee shall authenticate and shall deliver any Securities which previously shall have been signed and delivered to
            the Trustee for authentication, and any Securities which such assuming Person thereafter shall cause to be signed and delivered to the Trustee for that purpose. All of the Securities so issued shall in all respects have the same legal rank and
            benefit under this CVR Agreement as the Securities theretofore or thereafter issued in accordance with the terms of this CVR Agreement as though all of such Securities had been issued at the date of the execution hereof.

       

      
        40

        
          

      

      

      

      (b)          In case of any such assumption,
          such changes in phraseology and form (but not in substance) may be made in the Securities thereafter to be issued as may be appropriate.

      

      

      (c)          In the event of any such
          assumption, the assigning Person shall be discharged from all obligations and covenants under this CVR Agreement and the Securities and may be liquidated and dissolved.

      

      

      Section 9.3         Opinion of Counsel to the Trustee. The Trustee, subject to the provisions of Sections 4.1 and 4.2, shall receive an Officer’s Certificate and Opinion of Counsel, prepared in accordance with Section 1.2 and Section 1.3, as conclusive evidence that any such consolidation, merger, sale or conveyance, and any such assumption, and any such liquidation or dissolution, complies with
          the applicable provisions of this CVR Agreement, and if a supplemental agreement is required in connection with such transaction, such supplemental agreement complies with this Article and that there has been compliance with all conditions
          precedent herein provided for or relating to such transaction.

      

      

      Section 9.4          Successors. All covenants, provisions and agreements in this CVR Agreement by or for the benefit of the Company, the Trustee or the Holders shall bind and inure to the benefit of their respective successors,
          assigns, heirs and personal representatives, whether so expressed or not. The Company may assign this CVR Agreement without the prior written consent of the other Parties to this CVR Agreement to one or more of its direct or indirect
          Subsidiaries, provided, however, that, subject to Section 9.2(a) and (b), in the event of any such assignment the Company shall remain subject to its obligations and
          covenants hereunder, including but not limited to its obligation to make the Milestone Payment.

      

      

      ARTICLE 10

      SUBORDINATION

      

      

      Section 10.1        Agreement to Subordinate. The Company agrees, and each Holder by accepting a Security hereunder agrees, that the Milestone Payment, all other obligations under this CVR Agreement and the Securities and any
          rights or claims relating thereto (collectively, the “Junior Obligations”) are subordinated in right of payment, to the extent and in the manner provided in this Article 10, to the prior payment in full in cash or cash equivalents of all Senior Obligations of the Company (whether outstanding on the date hereof or hereafter created, incurred, assumed or guaranteed), and that the subordination is for the benefit of the holders of such Senior Obligations.

       

      
        41

        
          

      

      

      

      Section 10.2        Liquidation; Dissolution; Bankruptcy. Upon any distribution to creditors of the Company in a liquidation or dissolution of the Company or in a bankruptcy, reorganization, insolvency, receivership or similar
          proceeding relating to the Company or its property, in an assignment for the benefit of creditors or any marshaling of the Company’s assets and liabilities:

      

      

      (a)         holders of Senior Obligations
          will be entitled to receive payment in full in cash or cash equivalents of all Senior Obligations of the Company (including interest after the commencement of any bankruptcy proceeding at the rate specified in the applicable Senior Obligation,
          whether or not permitted under such bankruptcy proceedings) before the Holders will be entitled to receive any payment of any kind with respect to the Junior Obligations; and

      

      

      (b)         until all Senior Obligations of
          the Company (as provided in clause (a) above) are paid in full in cash or cash equivalents, any distribution to which Holders would be entitled but for this Article 10
          will be made to holders of Senior Obligations of the Company, as their interests may appear.

      

      

      Section 10.3         Default on Senior Obligations. The Company may not make any payment or distribution to any Holder in respect of Junior Obligations or acquire from any Holder for cash or property any Junior Obligations:

      

      

      (a)          if any default on any Senior
          Obligations exceeding twenty-five million dollars ($25,000,000) in aggregate principal amount would occur as a result of such payment, distribution or acquisition;

      

      

      (b)          during the continuance of any
          payment default in respect of any Senior Obligations (after expiration of any applicable grace period) exceeding twenty-five million dollars ($25,000,000) in aggregate principal amount;

      

      

      (c)          if the maturity of any Senior
          Obligations representing more than twenty-five million dollars ($25,000,000) in aggregate principal amount is accelerated in accordance with its terms and such acceleration has not been rescinded; or

      

      

      (d)         following the occurrence of any
          default (other than a payment default, and after the expiration of any applicable grace period) with respect to any Senior Obligations with an aggregate principal amount of more than twenty-five million dollars ($25,000,000), the effect of which
          is to permit the holders of such Senior Obligations (or a trustee or agent acting on their behalf) to cause, with the giving of notice if required, the maturity of such Senior Obligations to be accelerated, for a period commencing upon the
          receipt by the Trustee (with a copy to the Company) of a written notice of such default from the representative of the holders of such Senior Obligations and ending when such Senior Obligations are paid in full in cash or cash equivalents or, if
          earlier, when such default is cured or waived.

       

      
        42

        
          

      

      

      

      Section 10.4         When Distribution Must Be Paid Over.

      

      

      (a)         In the event that the Trustee or
          any Holder receives any payment of any Junior Obligations at a time when such payment is prohibited by this Article 10, such payment will be held by the Trustee or such
          Holder, in trust for the benefit of, and will be paid forthwith over and delivered, upon written request, to, the holders of Senior Obligations of the Company as their interests may appear or their representative under the agreement, indenture or
          other document (if any) pursuant to which such Senior Obligations may have been issued, as their respective interests may appear, for application to the payment of all such Senior Obligations remaining unpaid to the extent necessary to pay such
          Senior Obligations in full in accordance with their terms, after giving effect to any concurrent payment or distribution to or for the holders of Senior Obligations.

      

      

      (b)         Any amount received by any
          Holder as a result of direct or indirect credit support for the Junior Obligations from any Affiliate of the Company shall be treated as payments received by such Holder from the Company that are subject to the provisions of this Article 10.

      

      

      (c)         With respect to the holders of
          Senior Obligations, the Trustee undertakes to perform only those obligations on the part of the Trustee as are specifically set forth in this Article 10, and no implied
          covenants or obligations with respect to the holders of Senior Obligations will be read into this CVR Agreement against the Trustee. The Trustee will not be deemed to owe any fiduciary duty to the holders of Senior Obligations, and will not be
          liable to any such holders if the Trustee pays over or distributes to or on behalf of Holders or the Company or any other Person money or assets to which any holders of Senior Obligations are then entitled by virtue of this Article 10, except if such payment is made as a result of the willful misconduct or gross negligence of the Trustee.

      

      

      Section 10.5        Notice by Company. The Company will promptly notify the Trustee of any facts known to the Company that would cause a payment of any Junior Obligations to violate this Article 10, but failure to give such notice will not affect the subordination of the Junior Obligations to the Senior Obligations as provided in this Article 10.

      

      

      Section 10.6         Subordination Effective Notwithstanding Deficiencies with Respect to Senior Obligations: Waiver of Right to Contest Senior Obligation: Reinstatement of Subordination Provisions.

      

      

      (a)         The Holders hereby agree that
          subordination provisions contained in this Article 10 are unconditional, irrespective of the validity, regularity or enforceability of the Senior Obligations, the
          absence of any action to enforce the same, any waiver or consent by any holder of Senior Obligations with respect to any provisions thereof, the recovery of any judgment against the Company, any action to enforce the same or any other
          circumstance which might otherwise constitute a legal or equitable discharge or defense. Without limiting the foregoing, and notwithstanding anything to the contrary contained elsewhere in this CVR Agreement, in the event that the amount of
          Senior Obligations are reduced or diminished for any reason (other than as a result of the payment in cash or cash equivalents thereof), whether because of the applicability of fraudulent conveyance or other applicable Laws, or any other
          invalidity or limitation on the amount of Senior Obligations, the subordination provisions thereof shall apply to the full amount of Senior Obligations (without giving effect to any
            reduction, invalidity or diminution thereof), and the turnover provisions hereunder shall be fully enforceable with respect to the full amount of Senior Obligations (without giving effect to any such reduction, invalidity or diminution
            thereof), even if the effect thereof is that there will be no (or a limited amount of) Senior Obligations to which the Junior Obligations are subrogated after the payment in full in cash of any of the remaining Senior Obligations (without
            giving effect to any reductions, invalidity or diminution thereof, except for reductions as a result of payments thereof in cash or cash equivalents).

       

      
        43

        
          

      

      

      

      (b)          The Trustee and the Holders
          agree that they shall not (and hereby waive any right to) take any action to contest or challenge (or assist or support any other Person in contesting or challenging), directly or indirectly, whether or not in any proceeding (including in any
          proceeding commenced by or against any Person under any provision of Title 11 of the United States Code, as now and hereinafter in effect, or any successor statute or under any other state or federal bankruptcy or insolvency Law, assignments for
          the benefit of creditors, formal or informal moratoria, compositions, extensions generally with creditors, or proceedings seeking reorganization, arrangement, or other similar relief), the validity or enforceability of the Senior Obligations.

      

      

      (c)        If any payment made or in respect
          to the Senior Obligations must be disgorged or returned for any reason, the Senior Obligations shall be reinstated hereunder and for all purposes of this Article 10
          (including the turnover provisions hereof) such payment shall be deemed to have never been made with respect to the Senior Obligations.

      

      

      Section 10.7        Subrogation. After all Senior Obligations are paid in full in cash or cash equivalents and until the Junior Obligations are paid in full, Holders will be subrogated to the rights of holders of Senior
          Obligations to receive distributions applicable to Senior Obligations to the extent that distributions otherwise payable to the Holders have been applied to the payment of Senior Obligations. The Holders by accepting the Securities acknowledge
          that to the extent that the Senior Obligations are determined to be unenforceable, or the Senior Obligations are subordinated to other obligations of the Company, such subrogation rights may be impaired.

      

      

      Section 10.8         Relative Rights. This Article 10 defines the relative rights of Holders and holders of Senior Obligations. Nothing in this CVR
          Agreement will:

      

      

      (a)          impair, as between the Company
          and Holders, the obligations of the Company under this CVR Agreement and the Securities; or

      

      

      (b)          affect the relative rights of
          Holders and creditors of the Company other than their rights in relation to holders of Senior Obligations.

       

      
        44

        
          

      

      

      

      (c)          If the Company fails because of
          this Article 10 to pay any amounts due in respect of the Securities on a due date in violation of Section

              8.1, the failure is still an Event of Default.

      

      

      Section 10.9         Subordination May Not Be Impaired by Company. No right of any holder of Senior Obligations to enforce the subordination of the Junior Obligations may be impaired by any act or failure to act by the Company or
          any Holder or by the failure of the Company or any Holder to comply with this CVR Agreement.

      

      

      Section 10.10      Distribution or Notice to Representative. Whenever a distribution is to be made or a notice given to holders of Senior Obligations, the distribution may be made and the notice given to their representative in
          accordance with the terms of the instrument or other agreement governing such Senior Obligations. Upon any payment or distribution of assets of the Company referred to in this Article

              10, the Trustee and the Holders will be entitled to rely upon any order or decree made by any court of competent jurisdiction or upon any certificate of such representative or of the liquidating trustee or agent or other Person
          making any distribution to the Trustee or to the Holders for the purpose of ascertaining the Persons entitled to participate in such distribution, the holders of the Senior Obligations and other obligations of the Company, the amount thereof or
          payable thereon, the amount or amounts paid or distributed thereon and all other facts pertinent thereto or to this Article 10.

      

      

      Section 10.11      Rights of the Trustee. Notwithstanding the provisions of this Article 10 or any other provision of this CVR Agreement, the Trustee
          will not be charged with knowledge of the existence of any facts that would prohibit the making of any payment or distribution by the Trustee, and the Trustee may continue to make payments on the Securities, unless the Trustee has received at its
          address for notice specified in Section 1.5 at least five (5) Business Days prior to the date of such payment written notice of facts that would cause the payment of
          any Junior Obligations to violate this Article 10. Only the Company or a representative of Senior Obligations may give the notice. Nothing in this Article 10 will impair the claims of, or payments to, the Trustee under or pursuant to Section 4.7.
          The Trustee in its individual or any other capacity may hold Senior Obligations with the same rights it would have if it were not the Trustee.

      

      

      Section 10.12      Authorization to Effect Subordination. Each Holder, by the Holder’s acceptance of the Securities, authorizes and directs the Trustee on such Holder’s behalf to take such action as may be necessary or
          appropriate to effectuate the subordination as provided in this Article 10, and appoints the Trustee to act as such Holder’s attorney-in-fact for any and all such
          purposes. If the Trustee (or any other Person acting on behalf of and at the direction of the Majority Holders) does not file a proper proof of claim or proof of debt in the form required in any proceeding referred to in Section 8.2 hereof at least thirty (30) days before the expiration of the time to file such claim, the representatives of the Senior Obligations are hereby authorized to file an appropriate
          claim for and on behalf of the Holders of the Securities.

      

      

      Section 10.13      Amendments. The provisions of this Article 10 are expressly made for the benefit of the holders from time to time of the Senior
          Obligations, and may not be amended or modified without the written consent of the representatives of the holders of all Senior Obligations.

       

      
        45

        
          

      

      

      

      [Signature Page Follows]

       

      
        46

        
          

      

      

      

      IN WITNESS WHEREOF, the Parties hereto have caused this CVR Agreement to be duly executed, all as of the day and year first above
          written.

      

      

      	 	
              BRISTOL-MYERS SQUIBB COMPANY

            
	 	 	 
	 	
              By:

            	
               

            
	 	 	
              Name:

            
	 	 	
              Title:

            
	 	 	 
	 	
              [____________], as the Trustee

            
	 	 	 
	 	
              By:

            	
               

            
	 	 	
              Name:

            
	 	 	
              Title:

            

      

      

      [Signature Page to CVR Agreement]

       

      
        
          

      

      
      

      

      ANNEX A

      

      

      THIS SECURITY IS A GLOBAL SECURITY WITHIN THE MEANING OF THE CONTINGENT VALUE RIGHTS AGREEMENT (THE “CVR AGREEMENT”) HEREINAFTER REFERRED TO AND IS REGISTERED IN THE NAME OF A DEPOSITARY OR A NOMINEE OF A DEPOSITARY OR A SUCCESSOR DEPOSITARY FOR THE BENEFIT OF THE BENEFICIAL OWNERS HEREOF. THIS
          SECURITY IS NOT EXCHANGEABLE FOR SECURITIES REGISTERED IN THE NAME OF A PERSON OTHER THAN THE DEPOSITARY OR ITS NOMINEE EXCEPT IN THE LIMITED CIRCUMSTANCES DESCRIBED IN THE CVR AGREEMENT, AND NO TRANSFER OF THIS SECURITY (OTHER THAN A TRANSFER OF
          THIS SECURITY AS A WHOLE BY THE DEPOSITARY TO A NOMINEE OF THE DEPOSITARY OR BY A NOMINEE OF THE DEPOSITARY TO THE DEPOSITARY OR ANOTHER NOMINEE OF THE DEPOSITARY) MAY BE REGISTERED EXCEPT IN THE LIMITED CIRCUMSTANCES DESCRIBED IN THE CVR
          AGREEMENT.

      

      

      UNLESS AND UNTIL IT IS EXCHANGED IN WHOLE OR IN PART FOR SECURITIES IN DIRECT REGISTRATION FORM, THIS SECURITY MAY NOT BE TRANSFERRED
          EXCEPT AS A WHOLE BY THE DEPOSITARY TO A NOMINEE OF THE DEPOSITARY OR BY A NOMINEE OF THE DEPOSITARY TO THE DEPOSITARY OR ANOTHER NOMINEE OF THE DEPOSITARY OR BY THE DEPOSITARY OR ANY SUCH NOMINEE TO A SUCCESSOR DEPOSITARY OR A NOMINEE OF SUCH
          SUCCESSOR DEPOSITARY. UNLESS THIS SECURITY IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY, A NEW YORK CORPORATION (“DTC”) TO THE ISSUER OR
          ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE, OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF CEDE & CO. OR IN SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC (AND ANY PAYMENT IS MADE TO CEDE
          & CO. OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC), ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL INASMUCH AS THE REGISTERED OWNER HEREOF, CEDE & CO.,
          HAS AN INTEREST HEREIN.

      

      

      BRISTOL-MYERS SQUIBB COMPANY

      

      

      	
              No.

            	
              Certificate for

            	
              Contingent Value Rights

            
	
              CUSIP

            	
              [________]

            	 

      

      

      This certifies that __________, or registered assigns (the “Holder”),

          is the registered holder of the number of Contingent Value Rights (“CVRs” or “Securities”)
          set forth above. Each CVR entitles the Holder, subject to the provisions contained herein and in the CVR Agreement referred to on the reverse hereof, to payments from Bristol-Myers Squibb Company, a Delaware corporation (the “Company”), in an amounts and in the forms determined pursuant to the provisions set forth on the reverse hereof and as more fully described in the CVR Agreement referred to
          on the reverse hereof. Such payments shall be made by the Company on the Milestone Payment Date, as defined in the CVR Agreement referred to on the reverse hereof, in accordance with the terms of the CVR Agreement.

       

      
        A-1

        
          

      

      

      

      Payment of any amounts pursuant to this CVR certificate shall be made only to the registered Holder (as defined in the CVR Agreement)
          of this CVR certificate. Such payment shall be made in the Borough of Manhattan, The City of New York, or at any other office or agency maintained by the Company for such purpose, in such coin or currency of the United States of America as at the
          time is legal tender for the payment of public and private debts; provided, however, the Company may pay such amounts by wire transfer or check payable in such money. [Trustee] has been initially appointed as Paying Agent at its office or agency
          in the Borough of Manhattan, The City of New York.

      

      

      Reference is hereby made to the further provisions of this CVR certificate set forth on the reverse hereof, which further provisions
          shall for all purposes have the same effect as if set forth at this place.

      

      

      Unless the certificate of authentication hereon has been duly executed by the Trustee referred to on the reverse hereof by manual
          signature, this CVR certificate shall not be entitled to any benefit under the CVR Agreement, or be valid or obligatory for any purpose.

      

      

      IN WITNESS WHEREOF, the Company has caused this instrument to be duly executed.

      

      

      Dated: [•]

      

      

      	 	
              By:

            	
               

            
	 	 	
              Name:

            
	 	 	
              Title:

            

      

      

      [Form of Reverse of CVR certificate]

      

      

      1.          This CVR certificate is issued under and in accordance with the Contingent Value Rights Agreement, dated as of [______],
          [____] (the “CVR Agreement”), between the Company and [Trustee], a [_______], as trustee (the “Trustee,”

          which term includes any successor Trustee under the CVR Agreement), and is subject to the terms and provisions contained in the CVR Agreement, to all of which terms and provisions the Holder of this CVR certificate consents by acceptance hereof.
          The CVR Agreement is hereby incorporated herein by reference and made a part hereof. Reference is hereby made to the CVR Agreement for a full statement of the respective rights, limitations of rights, duties, obligations and immunities thereunder
          of the Company, the Trustee and the Holders of the CVRs. All capitalized terms used in this CVR certificate without definition shall have the respective meanings ascribed to them in the CVR Agreement. Copies of the CVR Agreement can be obtained
          by contacting the Trustee.

      

      

      2.           On the Milestone Payment Date, the Company shall make the payments required by Section 3.1(c) of the CVR Agreement to the Trustee, for further distribution by the Trustee to the Holders in accordance with Section

              3.1(c) of the CVR Agreement.

      

      

      3.           In the event of any conflict between this CVR certificate and the CVR Agreement, the CVR Agreement shall govern and
          prevail.

       

      
        A-2

        
          

      

      

      

      4.          The Milestone Payment, if any, and interest thereon, if any, shall be payable by the Company in such coin or currency of
          the United States of America as at the time is legal tender for the payment of public and private debts; provided, however, that such amounts may be paid check or wire transfer payable in such money. [Trustee] has been initially appointed as Paying Agent at its office or agency in the Borough of Manhattan, The City of New York.

      

      

      5.           If an Event of Default occurs and is continuing, either the Trustee may or the Majority Holders, by notice to the Company
          and to the Trustee shall bring suit in accordance with the terms and conditions of the CVR Agreement to protect the rights of the Holders, including to obtain payment of all amounts then due and payable, with interest at the Default Interest Rate
          from the date of the Event of Default through the date payment is made or duly provided for.

      

      

      6.         No reference herein to the CVR Agreement and no provision of this CVR certificate or of the CVR Agreement shall alter or
          impair the obligation of the Company, which is absolute and unconditional, to pay any amounts determined pursuant to the terms hereof and of the CVR Agreement at the times, place and amount, and in the manner, herein prescribed.

      

      

      7.           Each Milestone Payment or any other right, claim or payment of any kind under this CVR certificate, if any, shall be
          subordinated in right of payment, as set forth in Article 10 of the CVR Agreement, to the prior payment in full in cash or cash equivalents of all Senior Obligations whether outstanding on the date of the CVR Agreement or thereafter incurred.

      

      

      8.         As provided in the CVR Agreement and subject to certain limitations therein set forth, the transfer of the CVRs represented
          by this CVR certificate is registrable on the Security Register, upon surrender of this CVR certificate for registration of transfer at the office or agency of the Company maintained for such purpose in the Borough of Manhattan, The City of New
          York, duly endorsed by, or accompanied by a written instrument of transfer in form satisfactory to the Company and the Security Registrar duly executed by, the Holder hereof or his attorney duly authorized in writing, and thereupon one or more
          new CVR certificates or Direct Registration Securities, for the same amount of CVRs, will be issued to the designated transferee or transferees. The Company hereby initially designates the office of [Trustee] at [Address], New York, New York [Zip
          Code] as the office for registration of transfer of this CVR certificate.

      

      

      9.          As provided in the CVR Agreement and subject to certain limitations therein set forth, this CVR certificate is
          exchangeable for one or more CVR certificates or Direct Registration Securities representing the same number of CVRs as represented by this CVR certificate as requested by the Holder
            surrendering the same.

      

      

      10.        No service charge will be made for any registration of transfer or exchange of CVRs, but the Company may require payment of
          a sum sufficient to cover all documentary, stamp or similar issue or transfer taxes or other governmental charges payable in connection with any registration of transfer or exchange.

      

      

      11.        Prior to the time of due presentment of this CVR certificate for registration of transfer, the Company, the Trustee and any
          agent of the Company or the Trustee may treat the Person in whose name this CVR certificate is registered as the owner hereof for all purposes, and neither the Company, the Trustee nor any agent shall be affected by notice to the contrary.

       

      
        A-3

        
          

      

      

      

      12.           Neither the Company nor the Trustee has any duty or obligation to the holder of this CVR certificate, except as
          expressly set forth herein or in the CVR Agreement.

       

      
        A-4

        
          

      

      

      

      TRUSTEE’S CERTIFICATE OF AUTHENTICATION

      

      

      This is one of the Global Securities referred to in the within-mentioned CVR Agreement.

      

      

      	 	
              [__________], as the Trustee

            

      

      

      Dated: [•]

      

      

      	 	
              By:

            	
               

            
	 	 	
              Authorized Signatory

            

       

      
        A-5

        
          

      

      
      

      

      Annex B

      

      

      Form of Assignment and Assumption Agreement

      

      

      ASSIGNMENT AND ASSUMPTION AGREEMENT, made as of [_____], [_____] (this “Agreement”),

          between Bristol-Myers Squibb Company, a Delaware corporation (“Assignor”), and [_____], a [___] (“Assignee”).

          Unless otherwise defined herein, capitalized terms used in this Agreement shall have the meanings given to them in the CVR Agreement referred to below.

      

      

      W I T N E S S E T H:

      

      

      WHEREAS, Assignor and [Trustee], as trustee (the “Trustee”)

          are parties to a Contingent Value Rights Agreement dated as of [____], [_____] (the “CVR Agreement”); and

      

      

      WHEREAS, Assignor and Assignee desire to execute and deliver this Agreement evidencing the assignment to Assignee of due and punctual
          payment of the Milestone Payment and the performance and observance of every covenant of the CVR Agreement of Assignor to be performed and observed and the assumption thereof by Assignee.

      

      

      NOW, THEREFORE, in consideration of the premises and for other good and valuable consideration, the receipt and sufficiency of which
          is hereby acknowledged, Assignor and Assignee hereby agree as follows:

      

      

      
        
          	1.	
                  Assignment. Effective as of [______] (the “Assignment Date”), Assignor hereby assigns to Assignee, and Assignee hereby accepts the assignment of, the due and punctual payment of the Milestone Payment and the performance and observance of all
                      covenants and conditions of the CVR Agreement on the part of Assignor to be performed or observed.

                

        

      

      

      

      
        
          	2.	
                  Assumption. Effective as of the Assignment Date, Assignee hereby assumes the due and punctual
                      payment of the Milestone Payment and the performance and observance of all covenants and conditions of the CVR Agreement on the part of Assignor to be performed or observed.

                

        

      

      

      

      
        
          	3.	
                  Successors and Assigns. This Agreement shall be binding upon and shall inure to the benefit
                      of the respective parties hereto and their respective successors and assigns.

                

        

      

      

      

      
        
          	4.	
                  Governing Law. This Agreement shall be governed by, construed and enforced in accordance with
                      the laws of New York, without giving effect to the principles of conflicts of laws thereof.

                

        

      

      

      

      
        
          	5.	
                  Counterparts. This Agreement may be executed in one or more counterparts, each of which shall
                      be deemed an original but all of which together will constitute one and the same instrument.

                

        

      

       

      
        B-1

        
          

      

      

      

      IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed, all as of the day and year first above written.

      

      

      	 	
              BRISTOL-MYERS SQUIBB COMPANY

            
	 	 	 
	 	
              By:

            	
               

            
	 	 	
              Name:

            
	 	 	
              Title:

            
	 	 	 
	 	
              [ASSIGNEE]

            
	 	 	 
	 	
              By:

            	
               

            
	 	 	
              Name:

            
	 	 	
              Title:

            

      

      

    

  

   

    

  B-2

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00290-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00290-of-00352.parquet"}]]